<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName archivearticle3.dtd?>
<?SourceDTD.Version 3.0?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Hum Mutat</journal-id>
    <journal-id journal-id-type="iso-abbrev">Hum. Mutat</journal-id>
    <journal-id journal-id-type="doi">10.1002/(ISSN)1098-1004</journal-id>
    <journal-id journal-id-type="publisher-id">HUMU</journal-id>
    <journal-title-group>
      <journal-title>Human Mutation</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1059-7794</issn>
    <issn pub-type="epub">1098-1004</issn>
    <publisher>
      <publisher-name>John Wiley and Sons Inc.</publisher-name>
      <publisher-loc>Hoboken</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6282714</article-id>
    <article-id pub-id-type="doi">10.1002/humu.23613</article-id>
    <article-id pub-id-type="publisher-id">HUMU23613</article-id>
    <article-categories>
      <subj-group subj-group-type="overline">
        <subject>Mutation Update</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Mutation Updates</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Mucopolysaccharidosis type VI (MPS VI) and molecular analysis: Review and classification of published variants in the <italic>ARSB</italic> gene</article-title>
      <alt-title alt-title-type="left-running-head">TOMANIN et al.</alt-title>
    </title-group>
    <contrib-group>
      <contrib id="humu23613-cr-0001" contrib-type="author" corresp="yes">
        <name>
          <surname>Tomanin</surname>
          <given-names>Rosella</given-names>
        </name>
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3346-9900</contrib-id>
        <address>
          <email>rosella.tomanin@unipd.it</email>
        </address>
        <xref ref-type="aff" rid="humu23613-aff-0001">
          <sup>1</sup>
        </xref>
        <xref ref-type="author-notes" rid="humu23613-note-0002">
          <sup>†</sup>
        </xref>
      </contrib>
      <contrib id="humu23613-cr-0002" contrib-type="author">
        <name>
          <surname>Karageorgos</surname>
          <given-names>Litsa</given-names>
        </name>
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0732-8183</contrib-id>
        <xref ref-type="aff" rid="humu23613-aff-0002">
          <sup>2</sup>
        </xref>
        <xref ref-type="author-notes" rid="humu23613-note-0002">
          <sup>†</sup>
        </xref>
      </contrib>
      <contrib id="humu23613-cr-0003" contrib-type="author">
        <name>
          <surname>Zanetti</surname>
          <given-names>Alessandra</given-names>
        </name>
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4120-6262</contrib-id>
        <xref ref-type="aff" rid="humu23613-aff-0001">
          <sup>1</sup>
        </xref>
        <xref ref-type="author-notes" rid="humu23613-note-0002">
          <sup>†</sup>
        </xref>
      </contrib>
      <contrib id="humu23613-cr-0004" contrib-type="author">
        <name>
          <surname>Al‐Sayed</surname>
          <given-names>Moeenaldeen</given-names>
        </name>
        <xref ref-type="aff" rid="humu23613-aff-0003">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib id="humu23613-cr-0005" contrib-type="author">
        <name>
          <surname>Bailey</surname>
          <given-names>Mitch</given-names>
        </name>
        <xref ref-type="aff" rid="humu23613-aff-0004">
          <sup>4</sup>
        </xref>
      </contrib>
      <contrib id="humu23613-cr-0006" contrib-type="author">
        <name>
          <surname>Miller</surname>
          <given-names>Nicole</given-names>
        </name>
        <xref ref-type="aff" rid="humu23613-aff-0004">
          <sup>4</sup>
        </xref>
      </contrib>
      <contrib id="humu23613-cr-0007" contrib-type="author">
        <name>
          <surname>Sakuraba</surname>
          <given-names>Hitoshi</given-names>
        </name>
        <xref ref-type="aff" rid="humu23613-aff-0005">
          <sup>5</sup>
        </xref>
      </contrib>
      <contrib id="humu23613-cr-0008" contrib-type="author">
        <name>
          <surname>Hopwood</surname>
          <given-names>John J.</given-names>
        </name>
        <xref ref-type="aff" rid="humu23613-aff-0002">
          <sup>2</sup>
        </xref>
      </contrib>
    </contrib-group>
    <aff id="humu23613-aff-0001">
      <label>
        <sup>1</sup>
      </label>
      <named-content content-type="organisation-division">Laboratory of Diagnosis and Therapy of Lysosomal Disorders</named-content>
      <named-content content-type="organisation-division">Department of Women's and Children's Health</named-content>
      <institution>University of Padova and “Fondazione Istituto di Ricerca Pediatrica Città della Speranza”</institution>
      <named-content content-type="city">Padova</named-content>
      <country country="IT">Italy</country>
    </aff>
    <aff id="humu23613-aff-0002">
      <label>
        <sup>2</sup>
      </label>
      <named-content content-type="organisation-division">Hopwood Centre for Neurobiology</named-content>
      <institution>South Australian Health and Medical Research Institute</institution>
      <named-content content-type="city">Adelaide</named-content>
      <country country="AU">Australia</country>
    </aff>
    <aff id="humu23613-aff-0003">
      <label>
        <sup>3</sup>
      </label>
      <institution>King Faisal Specialist Hospital and Research Centre</institution>
      <named-content content-type="city">Riyadh</named-content>
      <country country="SA">Saudi Arabia</country>
    </aff>
    <aff id="humu23613-aff-0004">
      <label>
        <sup>4</sup>
      </label>
      <institution>BioMarin Pharmaceutical Inc.</institution>
      <named-content content-type="city">Novato</named-content>
      <named-content content-type="country-part">CA</named-content>
      <country country="US">United States</country>
    </aff>
    <aff id="humu23613-aff-0005">
      <label>
        <sup>5</sup>
      </label>
      <named-content content-type="organisation-division">Department of Clinical Genetics</named-content>
      <institution>Meiji Pharmaceutical University</institution>
      <named-content content-type="city">Tokyo</named-content>
      <country country="JP">Japan</country>
    </aff>
    <author-notes>
      <corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>Rosella Tomanin, Laboratory of Diagnosis and Therapy of Lysosomal Disorders, Department of Women's and Children's Health SDB, University of Padova, Padova, Italy.<break/>Email: <email>rosella.tomanin@unipd.it</email><break/></corresp>
      <fn id="humu23613-note-0002">
        <label>†</label>
        <p>These authors contributed equally to this work.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="epub">
      <day>17</day>
      <month>9</month>
      <year>2018</year>
    </pub-date>
    <pub-date pub-type="ppub">
      <month>12</month>
      <year>2018</year>
    </pub-date>
    <volume>39</volume>
    <issue>12</issue>
    <issue-id pub-id-type="doi">10.1002/humu.2018.39.issue-12</issue-id>
    <fpage>1788</fpage>
    <lpage>1802</lpage>
    <history>
      <date date-type="received">
        <day>14</day>
        <month>5</month>
        <year>2018</year>
      </date>
      <date date-type="rev-recd">
        <day>10</day>
        <month>8</month>
        <year>2018</year>
      </date>
      <date date-type="accepted">
        <day>13</day>
        <month>8</month>
        <year>2018</year>
      </date>
    </history>
    <permissions>
      <!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 Wiley Periodicals, Inc. <copyright-statement>-->
      <copyright-statement content-type="article-copyright">© 2018 The Authors. <italic>Human Mutation</italic> published by Wiley Periodicals, Inc.</copyright-statement>
      <license license-type="creativeCommonsBy-nc-nd">
        <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
      </license>
    </permissions>
    <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:HUMU-39-1788.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Maroteaux–Lamy syndrome (MPS VI) is an autosomal recessive lysosomal storage disorder caused by pathogenic <italic>ARSB</italic> gene variants, commonly diagnosed through clinical findings and deficiency of the arylsulfatase B (ASB) enzyme. Detection of <italic>ARSB</italic> pathogenic variants can independently confirm diagnosis and render genetic counseling possible. In this review, we collect and summarize 908 alleles (201 distinct variants, including 3 polymorphisms previously considered as disease‐causing variants) from 478 individuals diagnosed with MPS VI, identified from literature and public databases. Each variant is further analyzed for clinical classification according to American College of Medical Genetics and Genomics (ACMG) guidelines. Results highlight the heterogeneity of <italic>ARSB</italic> alleles, with most unique variants (59.5%) identified as missense and 31.7% of unique alleles appearing once. Only 18% of distinct variants were previously recorded in public databases with supporting evidence and clinical significance. ACMG recommends publishing clinical and biochemical data that accurately characterize pathogenicity of new variants in association with reporting specific alleles. Variants analyzed were sent to ClinVar (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/">https://www.ncbi.nlm.nih.gov/clinvar/</ext-link>), and MPS VI locus‐specific database (<ext-link ext-link-type="uri" xlink:href="http://mps6-database.org">http://mps6-database.org</ext-link>) where they will be available. High clinical suspicion coupled with diagnostic testing for deficient ASB activity and timely submission and classification of <italic>ARSB</italic> variants with biochemical and clinical data in public databases is essential for timely diagnosis of MPS VI.</p>
    </abstract>
    <kwd-group kwd-group-type="author-generated">
      <kwd id="humu23613-kwd-0001">
        <italic>ARSB</italic>
      </kwd>
      <kwd id="humu23613-kwd-0002">arylsulfatase B</kwd>
      <kwd id="humu23613-kwd-0003">ASB</kwd>
      <kwd id="humu23613-kwd-0004">databases</kwd>
      <kwd id="humu23613-kwd-0005">lysosomal storage disorder</kwd>
      <kwd id="humu23613-kwd-0006">MPS VI</kwd>
      <kwd id="humu23613-kwd-0007">variants</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>BioMarin Pharmaceutical Inc</funding-source>
      </award-group>
      <award-group>
        <funding-source>University of Padova</funding-source>
      </award-group>
    </funding-group>
    <counts>
      <fig-count count="5"/>
      <table-count count="3"/>
      <page-count count="15"/>
      <word-count count="10379"/>
    </counts>
    <custom-meta-group>
      <custom-meta>
        <meta-name>source-schema-version-number</meta-name>
        <meta-value>2.0</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>component-id</meta-name>
        <meta-value>humu23613</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>cover-date</meta-name>
        <meta-value>December 2018</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>details-of-publishers-convertor</meta-name>
        <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.5.3 mode:remove_FC converted:06.12.2018</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
  <notes>
    <p content-type="self-citation">
      <mixed-citation publication-type="journal" id="humu23613-cit-0118"><string-name><surname>Tomanin</surname><given-names>R</given-names></string-name>, <string-name><surname>Karageorgos</surname><given-names>L</given-names></string-name>, <string-name><surname>Zanetti</surname><given-names>A</given-names></string-name>, et al. <article-title>Mucopolysaccharidosis type VI (MPS VI) and molecular analysis: Review and classification of published variants in the <italic>ARSB</italic> gene</article-title>. <source xml:lang="en">Human Mutation</source>. <year>2018</year>;<volume>39</volume>:<fpage>1788</fpage>–<lpage>1802</lpage>. <pub-id pub-id-type="doi">10.1002/humu.23613</pub-id><pub-id pub-id-type="pmid">30118150</pub-id></mixed-citation>
    </p>
    <fn-group>
      <fn id="humu23613-note-0001">
        <p>Communicated by Johannes Zschocke</p>
      </fn>
    </fn-group>
  </notes>
</front>
<body>
  <sec id="humu23613-sec-0010">
    <label>1</label>
    <title>BACKGROUND</title>
    <p>Mucopolysaccharidosis type VI (MPS VI, Maroteaux–Lamy syndrome, MIM# 253200) is a rare autosomal recessive disease caused by pathogenic variants in the arylsulfatase B (<italic>ARSB</italic>) gene, coding for one of the enzymes deputed to the degradation of mucopolysaccharides within lysosomes. Pathogenic <italic>ARSB</italic> variants result in deficient activity of the lysosomal enzyme N‐acetylgalactosamine 4‐sulfatase (arylsulfatase B, ASB, EC 3.1.6.12), causing excessive lysosomal storage and elevated urinary excretion of ASB enzyme substrates, specifically the glycosaminoglycans (GAGs) dermatan sulfate and chondroitin‐4‐sulfate. Increased lysosomal GAG storage causes cellular injury and can result in a diverse range of clinical manifestations (Jurecka et al., <xref rid="humu23613-bib-0046" ref-type="ref">2011b</xref>; Valayannopoulos, Nicely, Harmatz, &amp; Turbeville, <xref rid="humu23613-bib-0100" ref-type="ref">2010</xref>; Wang, Bodamer, Watson, &amp; Wilcox, <xref rid="humu23613-bib-0108" ref-type="ref">2011</xref>).</p>
    <p>The prevalence of MPS VI varies among populations, with estimates ranging from 0.0132 per 100,000 live births in Poland to 8.0 per 100,000 live births in Saudi Arabia to 20.0 per 100,000 live births in Monte Santo, a small town in Brazil (Costa‐Motta et al., <xref rid="humu23613-bib-0017" ref-type="ref">2014</xref>; Jurecka, Ługowska, Golda, Czartoryska, &amp; Tylki‐Szymańska, <xref rid="humu23613-bib-0052" ref-type="ref">2015</xref>; Moammar, Cheriyan, Mathew, &amp; Al‐Sannaa, <xref rid="humu23613-bib-0077" ref-type="ref">2010</xref>; Vairo et al., <xref rid="humu23613-bib-0099" ref-type="ref">2015</xref>). While several variables likely influence prevalence rates across populations, it is expected that populations with higher degrees of consanguinity display a higher prevalence of the disease (Baehner et al., <xref rid="humu23613-bib-0004" ref-type="ref">2005</xref>; Costa‐Motta et al., <xref rid="humu23613-bib-0017" ref-type="ref">2014</xref>). Importantly, disease prevalence is likely underestimated in all populations since these epidemiological studies generally rely on clinical identification of disease rather than prenatal or newborn screening (Valayannopoulos et al., <xref rid="humu23613-bib-0100" ref-type="ref">2010</xref>).</p>
    <p>MPS VI is clinically heterogeneous. Age of onset, rate of disease progression, and clinical manifestations vary widely among individuals. MPS VI can manifest with growth retardation/short stature, coarse facial features, joint stiffness, dysostosis multiplex, hepatosplenomegaly, corneal clouding, macrocephaly, hearing loss, and cardiac and respiratory compromise. Unlike many other lysosomal storage disorders (LSDs), mental development is generally normal, although other symptoms (such as hearing loss) may partially cause developmental delay in some individuals. MPS VI, like other LSDs, is progressive in nature. Untreated patients will continue to deteriorate as GAGs further accumulate within the cell (Jurecka et al., <xref rid="humu23613-bib-0046" ref-type="ref">2011b</xref>; Vairo et al., <xref rid="humu23613-bib-0099" ref-type="ref">2015</xref>; Valayannopoulos et al., <xref rid="humu23613-bib-0100" ref-type="ref">2010</xref>; Wang et al., <xref rid="humu23613-bib-0108" ref-type="ref">2011</xref>).</p>
    <p>Historically, individuals with MPS VI have been classified into severity groups based on factors such as age of onset, height, and urinary GAG level. Patients with the classical form of MPS VI (sometimes referred to as severe or rapidly progressing) generally present within the first 3 years of life and display elevated urinary GAG levels (generally &gt;100 μg/mg creatinine). In contrast, patients with non‐classical MPS VI (sometimes referred to as atypical, attenuated, or slowly progressing) present later in life with more subtle disease manifestations, and may demonstrate slightly elevated (generally &lt;100 μg/mg creatinine) or near normal urinary GAG levels (Vairo et al., <xref rid="humu23613-bib-0099" ref-type="ref">2015</xref>; Valayannopoulos et al., <xref rid="humu23613-bib-0100" ref-type="ref">2010</xref>). Intermediate forms are also observed. Fibroblasts and leukocytes of individuals with MPS VI demonstrate absent or reduced ASB enzyme activity compared with healthy controls (Valayannopoulos et al., <xref rid="humu23613-bib-0100" ref-type="ref">2010</xref>). In addition, a non‐classical “cardiac phenotype” has been described in some patients with MPS VI. This form manifests later in adulthood with primarily cardiac features such as valvular disease, cardiomyopathy, and/or acute heart failure, although other symptoms (such as musculoskeletal abnormalities) may also be present (Golda, Jurecka, &amp; Tylki‐Szymanska, <xref rid="humu23613-bib-0029" ref-type="ref">2012</xref>; Jurecka, Golda, Opoka‐Winiarska, Piotrowska, &amp; Tylki‐Szymańska, <xref rid="humu23613-bib-0045" ref-type="ref">2011a</xref>; Thümler et al., <xref rid="humu23613-bib-0096" ref-type="ref">2012</xref>).</p>
    <p>MPS VI is diagnosed through a combination of clinical findings and demonstration of deficient or absent ASB enzyme activity, in conjunction with normal activity of control enzymes, mainly sulfatases, to exclude a multiple sulfatase deficiency. Detection of pathogenic <italic>ARSB</italic> variants in the proband and in both parents (trio analysis) independently confirms diagnosis and renders genetic counseling possible. However, this approach may be problematic due to the high proportion of private mutations in MPS VI, thus considering the possibility to identify gene variants that are not yet associated with a clinical phenotype.</p>
    <p>Guidelines from the American College of Medical Genetics and Genomics (ACMG) recommend that gene variants be published in association with clinical classification and validating data (Richards et al., <xref rid="humu23613-bib-0089" ref-type="ref">2015</xref>). In this study, we collected and analyzed all the <italic>ARSB</italic> variants reported in the literature and in public databases. Of the 201 unique <italic>ARSB</italic> variants summarized here, only 18% had been previously recorded in public databases (ClinVar, EmvClass, ClinVitae) in association with supporting evidence/clinical classification. The present update illustrates the heterogeneity of alleles associated with MPS VI, the need of a critical evaluation and correct classification of the identified variants, and the lack of prior representation in publicly available variant databases of characterized <italic>ARSB</italic> alleles. Variants analyzed in the present paper have been sent to ClinVar (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/">https://www.ncbi.nlm.nih.gov/clinvar/</ext-link>), where they will be publicly available.</p>
    <p>We emphasize the importance to maintain high clinical suspicion during MPS VI diagnosis, as many <italic>ARSB</italic> alleles identified via molecular testing alone may have yet to be formally classified as MPS VI‐associated and cannot be considered diagnostic <italic>per se</italic>. Timely submission and classification of <italic>ARSB</italic> variants in public databases, in association with biochemical and clinical data, will help facilitate timely future diagnoses of MPS VI.</p>
  </sec>
  <sec id="humu23613-sec-0020">
    <label>2</label>
    <title>METHODOLOGY</title>
    <p>To identify all reported pathogenic <italic>ARSB</italic> variants, a literature search was performed in Embase on October 26, 2017 using the population, intervention and comparators, outcome (PICO) framework where the population was MPS VI (and relevant synonyms) and the outcome was genetic variant (and relevant synonyms); intervention and comparators were not applicable. Results were limited to studies in humans and conference abstracts were excluded. As case reports containing variant data are often not indexed to reflect the presence of this information, a targeted MPS VI case report search was also performed in Embase on September 13, 2017 to supplement the results. The search strategies are described in detail in <xref rid="humu23613-supl-0001" ref-type="supplementary-material">Supp. Mat. S1</xref>. Manual searching of relevant journals not indexed in Embase was also performed. Each identified publication was screened by a single reviewer for information regarding <italic>ARSB</italic> variants. Reports of individuals with <italic>ARSB</italic> variants, where variants were reported as linked to MPS VI, were extracted and assessed for redundant reporting to the extent possible.</p>
    <p>Public databases were accessed via searches for “ARSB” in ClinVar, EmvClass, ClinVitae, and Human Gene Mutation Database (HGMD) (Hart et al., <xref rid="humu23613-bib-0036" ref-type="ref">2014</xref>; Stenson et al., <xref rid="humu23613-bib-0095" ref-type="ref">2003</xref>). Identified variants were compared with those from the literature search.</p>
    <p>For the three‐dimensional visualization of arylsulfatase B, an image was created using the PyMOL Molecular Graphics System, Version 1.8 Schrödinger, LLC with atomic coordinates from Brookhaven Protein Data Bank accession number 1FSU (Bond et al., <xref rid="humu23613-bib-0006" ref-type="ref">1997</xref>).</p>
    <p>All variants were described according to the NCBI Reference Sequence NM_000046.4 and the corresponding protein sequence NP_000037.2. In cases where the reported variant did not reference a particular sequence, coordinates were mapped to NM_000046.4 [e.g., “deletion of exon 4” to “c.(690+1_691‐1)_(898+1_899‐1)del”]. Variants cDNA and protein annotations were further checked through “'Name checker'” tool (<ext-link ext-link-type="uri" xlink:href="https://mutalyzer.nl/">https://mutalyzer.nl/</ext-link>) according to the HGVS nomenclature v15.11 (<ext-link ext-link-type="uri" xlink:href="https://varnomen.hgvs.org/">https://varnomen.hgvs.org/</ext-link>) and “VariantValidator” tool (<ext-link ext-link-type="uri" xlink:href="https://variantvalidator.org">https://variantvalidator.org</ext-link>), and corrected if necessary. In case of discrepancies in amino acid sequence impact of coding variants, the variant was simulated and translated <italic>in silico</italic> using NM_000046.4. All discrepancies and other misreported variants found in our literature analysis were collected in Table <xref rid="humu23613-tbl-0001" ref-type="table">1</xref>.</p>
    <table-wrap id="humu23613-tbl-0001" xml:lang="en" orientation="portrait" position="float">
      <label>Table 1</label>
      <caption>
        <p>Summary of misreported variants and corrections</p>
      </caption>
      <table frame="hsides" rules="groups">
        <col align="left" span="1"/>
        <col align="left" span="1"/>
        <col align="left" span="1"/>
        <col align="left" span="1"/>
        <col align="left" span="1"/>
        <col align="left" span="1"/>
        <col align="left" span="1"/>
        <thead>
          <tr style="border-bottom:solid 1px #000000">
            <th colspan="2" style="border-bottom:solid 1px #000000" align="left" rowspan="1">Paper Annotation</th>
            <th colspan="2" style="border-bottom:solid 1px #000000" align="left" rowspan="1">Correct Annotation</th>
            <th align="center" rowspan="1" colspan="1">Type of Error</th>
            <th align="center" rowspan="1" colspan="1">Error Source</th>
            <th align="center" rowspan="1" colspan="1">Notes</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.208_215del</td>
            <td align="left" rowspan="1" colspan="1">p.(P70fs<sup>*</sup>123)</td>
            <td align="left" rowspan="1" colspan="1">c.208_215del</td>
            <td align="left" rowspan="1" colspan="1">p.(Pro70Glyfs<sup>*</sup>54)</td>
            <td align="left" rowspan="1" colspan="1">Amino acid position</td>
            <td align="left" rowspan="1" colspan="1">Kantaputra et al. (2014)</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.213insGCCGCAC</td>
            <td align="left" rowspan="1" colspan="1">p.(Leu72Alafs<sup>*</sup>57)</td>
            <td align="left" rowspan="1" colspan="1">c.207_213dup</td>
            <td align="left" rowspan="1" colspan="1">p.(Leu72Alafs<sup>*</sup>57)</td>
            <td align="left" rowspan="1" colspan="1">c.DNA position</td>
            <td align="left" rowspan="1" colspan="1">Sandberg et al. (2008)</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.247_248delC</td>
            <td align="left" rowspan="1" colspan="1">p.(D83Qfs<sup>*</sup>43)</td>
            <td align="left" rowspan="1" colspan="1">c.247_248del</td>
            <td align="left" rowspan="1" colspan="1">p.(Asp83Glnfs<sup>*</sup>43)</td>
            <td align="left" rowspan="1" colspan="1">c.DNA position</td>
            <td align="left" rowspan="1" colspan="1">Jurecka et al. (2014b)</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.262_263insA</td>
            <td align="left" rowspan="1" colspan="1">p.(Pro89Alafs<sup>*</sup>38)</td>
            <td align="left" rowspan="1" colspan="1">c.263dup</td>
            <td align="left" rowspan="1" colspan="1">p.(Pro89Alafs<sup>*</sup>38)</td>
            <td align="left" rowspan="1" colspan="1">c.DNA position</td>
            <td align="left" rowspan="1" colspan="1">Jurecka et al. (2014b)</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.306_312delCTACCAG+146del</td>
            <td align="left" rowspan="1" colspan="1">p.(Y103SfsX9)</td>
            <td align="left" rowspan="1" colspan="1">c.306_312+146del</td>
            <td align="left" rowspan="1" colspan="1">p.(Tyr103Serfs<sup>*</sup>25)</td>
            <td align="left" rowspan="1" colspan="1">c.DNA position</td>
            <td align="left" rowspan="1" colspan="1">Uttarilli et al. (2015)</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.31091insCCTGAAG_delATACT</td>
            <td align="center" rowspan="1" colspan="1">—</td>
            <td align="left" rowspan="1" colspan="1">c.750_754delinsCCTGAAG</td>
            <td align="left" rowspan="1" colspan="1">p.(Glu250Aspfs<sup>*</sup>4)</td>
            <td align="left" rowspan="1" colspan="1">Reference sequence</td>
            <td align="left" rowspan="1" colspan="1">Jurecka et al. (2011b)</td>
            <td align="left" rowspan="1" colspan="1">The reference sequence used by Jurecka likely is NC_000005.9</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.356358 del</td>
            <td align="left" rowspan="1" colspan="1">p.(Y86del)</td>
            <td align="left" rowspan="1" colspan="1">c.356_358del</td>
            <td align="left" rowspan="1" colspan="1">p.(Pro119_Ser120delinsArg)</td>
            <td align="left" rowspan="1" colspan="1">Amino acid position</td>
            <td align="left" rowspan="1" colspan="1">Karageorgos et al. (2004)</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.375_376insT</td>
            <td align="left" rowspan="1" colspan="1">p.(Glu126<sup>*</sup>)</td>
            <td align="left" rowspan="1" colspan="1">c.375dup</td>
            <td align="left" rowspan="1" colspan="1">p.(Glu126<sup>*</sup>)</td>
            <td align="left" rowspan="1" colspan="1">c.DNA position</td>
            <td align="left" rowspan="1" colspan="1">Jurecka et al. (2012a)</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.436G&gt;T</td>
            <td align="left" rowspan="1" colspan="1">p.(Trp146Leu)</td>
            <td align="left" rowspan="1" colspan="1">c.437G&gt;T</td>
            <td align="left" rowspan="1" colspan="1">p.(Trp146Leu)</td>
            <td align="left" rowspan="1" colspan="1">c.DNA position</td>
            <td align="left" rowspan="1" colspan="1">Simonaro and Schuchman (1995)</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.496delT</td>
            <td align="left" rowspan="1" colspan="1">p.(Phe166Leufs<sup>*</sup>18)</td>
            <td align="left" rowspan="1" colspan="1">c.498del</td>
            <td align="left" rowspan="1" colspan="1">p.(Phe166Leufs<sup>*</sup>18)</td>
            <td align="left" rowspan="1" colspan="1">c.DNA position</td>
            <td align="left" rowspan="1" colspan="1">Uttarilli et al. (2015)</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.592C&gt;T</td>
            <td align="left" rowspan="1" colspan="1">p.(R197<sup>*</sup>)</td>
            <td align="left" rowspan="1" colspan="1">c.589C&gt;T</td>
            <td align="left" rowspan="1" colspan="1">p.(Arg197<sup>*</sup>)</td>
            <td align="left" rowspan="1" colspan="1">c.DNA position</td>
            <td align="left" rowspan="1" colspan="1">Petry et al. (2005)</td>
            <td align="left" rowspan="1" colspan="1">Also reported by Karageorgos et al. (2007b)</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.629_635del</td>
            <td align="left" rowspan="1" colspan="1">p.(Tyr210<sup>*</sup>)</td>
            <td align="left" rowspan="1" colspan="1">c.630_636del</td>
            <td align="left" rowspan="1" colspan="1">p.(Tyr210<sup>*</sup>)</td>
            <td align="left" rowspan="1" colspan="1">c.DNA position</td>
            <td align="left" rowspan="1" colspan="1">Karageorgos et al. (2007b)</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.659_660del</td>
            <td align="left" rowspan="1" colspan="1">p.(I220fs<sup>*</sup>5)</td>
            <td align="left" rowspan="1" colspan="1">c.659_660del</td>
            <td align="left" rowspan="1" colspan="1">p.(Ile220Serfs<sup>*</sup>5)</td>
            <td align="left" rowspan="1" colspan="1">Annotation error</td>
            <td align="left" rowspan="1" colspan="1">Uttarilli et al. (2015)</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.785insA</td>
            <td align="left" rowspan="1" colspan="1">p.(Asn262Lysfs<sup>*</sup>14)</td>
            <td align="left" rowspan="1" colspan="1">c.785dup</td>
            <td align="left" rowspan="1" colspan="1">p.(Asn262Lysfs<sup>*</sup>14)</td>
            <td align="left" rowspan="1" colspan="1">c.DNA position</td>
            <td align="left" rowspan="1" colspan="1">Chistiakov et al. (2014)</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.883_884dupTT</td>
            <td align="left" rowspan="1" colspan="1">p.(F295Ffs<sup>*</sup>42)</td>
            <td align="left" rowspan="1" colspan="1">c.883_884dup</td>
            <td align="left" rowspan="1" colspan="1">p.(Ile296Serfs<sup>*</sup>43)</td>
            <td align="left" rowspan="1" colspan="1">Amino acid position, annotation</td>
            <td align="left" rowspan="1" colspan="1">Ferla et al. (2015)</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.1036delG</td>
            <td align="left" rowspan="1" colspan="1">p.(E346Sfs<sup>*</sup>11)</td>
            <td align="left" rowspan="1" colspan="1">c.1036del</td>
            <td align="left" rowspan="1" colspan="1">p.(Glu346Serfs<sup>*</sup>13)</td>
            <td align="left" rowspan="1" colspan="1">Amino acid position, annotation</td>
            <td align="left" rowspan="1" colspan="1">Ferla et al. (2015)</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.1285_1286insT</td>
            <td align="left" rowspan="1" colspan="1">p.(His430Profs<sup>*</sup>5)</td>
            <td align="left" rowspan="1" colspan="1">c.1286dup</td>
            <td align="left" rowspan="1" colspan="1">p.(His430Profs<sup>*</sup>5)</td>
            <td align="left" rowspan="1" colspan="1">c.DNA position</td>
            <td align="left" rowspan="1" colspan="1">Isbrandt et al. (1994)</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.1325C&gt;T</td>
            <td align="left" rowspan="1" colspan="1">p.(T442R)</td>
            <td align="left" rowspan="1" colspan="1">c.1325C&gt;T</td>
            <td align="left" rowspan="1" colspan="1">p.(Thr442Met)</td>
            <td align="left" rowspan="1" colspan="1">Annotation error</td>
            <td align="left" rowspan="1" colspan="1">Karageorgos et al. (2007b)</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.1348G&gt;C</td>
            <td align="left" rowspan="1" colspan="1">p.(Trp450Cys)</td>
            <td align="left" rowspan="1" colspan="1">c.1350G&gt;C</td>
            <td align="left" rowspan="1" colspan="1">p.(Trp450Cys)</td>
            <td align="left" rowspan="1" colspan="1">c.DNA position</td>
            <td align="left" rowspan="1" colspan="1">Mathew et al. (2015)</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.1457A&gt;G</td>
            <td align="left" rowspan="1" colspan="1">p.(D486V)</td>
            <td align="left" rowspan="1" colspan="1">c.1457A&gt;T</td>
            <td align="left" rowspan="1" colspan="1">p.(Asp486Val)</td>
            <td align="left" rowspan="1" colspan="1">Annotation error</td>
            <td align="left" rowspan="1" colspan="1">Nouri et al. (<xref rid="humu23613-bib-0081" ref-type="ref">2012</xref>)</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">c.1531_1553del</td>
            <td align="left" rowspan="1" colspan="1">p.(V512Pfs*3)</td>
            <td align="left" rowspan="1" colspan="1">c.1534_1556del</td>
            <td align="left" rowspan="1" colspan="1">p.(Val512Profs*3)</td>
            <td align="left" rowspan="1" colspan="1">c.DNA position</td>
            <td align="left" rowspan="1" colspan="1">Petry et al. (2005)</td>
            <td align="left" rowspan="1" colspan="1">Also reported by Garcia et al. (2010)</td>
          </tr>
        </tbody>
      </table>
      <permissions>
        <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
      </permissions>
    </table-wrap>
    <p>For the variants collected, all the evidence available was exploited for variants analysis and clinical classification, according to the approach recommended by ACMG (Richards et al., <xref rid="humu23613-bib-0089" ref-type="ref">2015</xref>). Finally, all variants were submitted to ClinVar database with associated evidence and literature references (ClinVar accession numbers from SCV000802937 to SCV000803138).</p>
    <sec id="humu23613-sec-0030">
      <label>2.1</label>
      <title>ARSB gene structure</title>
      <p>The <italic>ARSB</italic> gene is located on chromosome 5q13‐14 and spans a region of 206 kb. <italic>ARSB</italic> contains eight exons which encode an mRNA transcript of 2228 base pairs and a protein of 533 amino acids, including a signal peptide at the N‐terminal (Brands et al., <xref rid="humu23613-bib-0008" ref-type="ref">2013a</xref>; Karageorgos et al., <xref rid="humu23613-bib-0057" ref-type="ref">2007b</xref>; Litjens et al., <xref rid="humu23613-bib-0065" ref-type="ref">1989</xref>; Litjens &amp; Hopwood, <xref rid="humu23613-bib-0068" ref-type="ref">2001</xref>; Peters et al., <xref rid="humu23613-bib-0084" ref-type="ref">1990</xref>). <italic>ARSB</italic> contains an alkaline phosphatase‐like domain and two conserved sulfatase regions near the N‐terminal (Figure <xref rid="humu23613-fig-0002" ref-type="fig">2</xref>; Bond et al., <xref rid="humu23613-bib-0006" ref-type="ref">1997</xref>; Peters et al., <xref rid="humu23613-bib-0084" ref-type="ref">1990</xref>).</p>
    </sec>
  </sec>
  <sec id="humu23613-sec-0040">
    <label>3</label>
    <title>VARIANTS</title>
    <sec id="humu23613-sec-0050">
      <label>3.1</label>
      <title>Overview and summary statistics</title>
      <p>A uniform summary of all <italic>ARSB</italic> variants identified in individuals with MPS VI was created based on the literature and database searches. The PICO search identified 208 records, the targeted case report search identified 198 records, and 5 additional records were identified from other sources. Removal of duplicates led to a total of 380 unique records. Manual screening yielded 74 publications containing 615 individuals with <italic>ARSB</italic> variant information. Duplicate entries were eliminated based on direct references (“patient reported previously”) and if the entries contained no conflicting attributes along with identical genotypes, ethnicities, gender, and age of diagnosis/start of ERT. This ultimately resulted in the aggregation of 908 alleles from 478 individuals diagnosed with MPS VI (<xref rid="humu23613-supl-0001" ref-type="supplementary-material">Supp. Mat. S2</xref>). No additional unpublished pathogenic variants were identified through the public database search. The 908 alleles encompassed 198 unique non‐polymorphic variants (<xref rid="humu23613-supl-0001" ref-type="supplementary-material">Supp. Mat. S3</xref>). However, <xref rid="humu23613-supl-0001" ref-type="supplementary-material">Supp. Mat. S3</xref> also reports three benign variants, highlighted in blue, which previously had been erroneously reported as disease‐causing variants. A shorter version of <xref rid="humu23613-supl-0001" ref-type="supplementary-material">Supp. Mat. S3</xref>, containing only variants described in more than one independent family, is represented by Table <xref rid="humu23613-tbl-0002" ref-type="table">2</xref>.</p>
      <table-wrap id="humu23613-tbl-0002" xml:lang="en" orientation="portrait" position="float">
        <label>Table 2</label>
        <caption>
          <p><italic>ARSB</italic> sequence variants identified in more than one independent family</p>
        </caption>
        <table frame="hsides" rules="groups">
          <col align="left" span="1"/>
          <col align="left" span="1"/>
          <col align="left" span="1"/>
          <col align="center" span="1"/>
          <col align="left" span="1"/>
          <col align="left" span="1"/>
          <thead>
            <tr style="border-bottom:solid 1px #000000">
              <th align="left" rowspan="1" colspan="1">Exon/Intron</th>
              <th align="left" rowspan="1" colspan="1">Nucleotide Change</th>
              <th align="left" rowspan="1" colspan="1">Predicted Amino Acid Change</th>
              <th align="center" rowspan="1" colspan="1">Number of Reports</th>
              <th align="left" rowspan="1" colspan="1">Clinical Significance</th>
              <th align="left" rowspan="1" colspan="1">Variant Identifier (ClinVar ID and/or dbSNP Number, if Available)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 1</td>
              <td align="left" rowspan="1" colspan="1">c.157G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Asp53Asn)</td>
              <td align="center" rowspan="1" colspan="1">6</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 1</td>
              <td align="left" rowspan="1" colspan="1">c.160G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Asp54Asn)</td>
              <td align="center" rowspan="1" colspan="1">5</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 1</td>
              <td align="left" rowspan="1" colspan="1">c.171G&gt;C</td>
              <td align="left" rowspan="1" colspan="1">p.(Trp57Cys)</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 1</td>
              <td align="left" rowspan="1" colspan="1">c.175G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Asp59Asn)</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 1</td>
              <td align="left" rowspan="1" colspan="1">c.215T&gt;G</td>
              <td align="left" rowspan="1" colspan="1">p.(Leu72Arg)</td>
              <td align="center" rowspan="1" colspan="1">13</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 1</td>
              <td align="left" rowspan="1" colspan="1">c.238del</td>
              <td align="left" rowspan="1" colspan="1">p.(Val80Cysfs*34)</td>
              <td align="center" rowspan="1" colspan="1">6</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1">ClinVar Allele ID: 15920; rs750845916</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 1</td>
              <td align="left" rowspan="1" colspan="1">c.245del</td>
              <td align="left" rowspan="1" colspan="1">p.(Leu82Argfs*32)</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 1</td>
              <td align="left" rowspan="1" colspan="1">c.245T&gt;G</td>
              <td align="left" rowspan="1" colspan="1">p.(Leu82Arg)</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1">rs750845916</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 1</td>
              <td align="left" rowspan="1" colspan="1">c.262C&gt;T</td>
              <td align="left" rowspan="1" colspan="1">p.(Gln88*)</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 1</td>
              <td align="left" rowspan="1" colspan="1">c.275C&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Thr92Lys)</td>
              <td align="center" rowspan="1" colspan="1">9</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 1</td>
              <td align="left" rowspan="1" colspan="1">c.275C&gt;T</td>
              <td align="left" rowspan="1" colspan="1">p.(Thr92Met)</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 1</td>
              <td align="left" rowspan="1" colspan="1">c.284G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Arg95Gln)</td>
              <td align="center" rowspan="1" colspan="1">6</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1">ClinVar Allele ID: 15923</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 1</td>
              <td align="left" rowspan="1" colspan="1">c.289C&gt;T</td>
              <td align="left" rowspan="1" colspan="1">p.(Gln97*)</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 1</td>
              <td align="left" rowspan="1" colspan="1">c.293T&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Leu98Gln)</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 1</td>
              <td align="left" rowspan="1" colspan="1">c.293T&gt;C</td>
              <td align="left" rowspan="1" colspan="1">p.(Leu98Pro)</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 1</td>
              <td align="left" rowspan="1" colspan="1">c.293T&gt;G</td>
              <td align="left" rowspan="1" colspan="1">p.(Leu98Arg)</td>
              <td align="center" rowspan="1" colspan="1">8</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 1</td>
              <td align="left" rowspan="1" colspan="1">c.305G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Arg102His)</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 1</td>
              <td align="left" rowspan="1" colspan="1">c.312G&gt;C</td>
              <td align="left" rowspan="1" colspan="1">p.(Gln104His)</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1">rs150087888</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 2</td>
              <td align="left" rowspan="1" colspan="1">c.332A&gt;C</td>
              <td align="left" rowspan="1" colspan="1">p.(His111Pro)</td>
              <td align="center" rowspan="1" colspan="1">5</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1">rs775780931</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 2</td>
              <td align="left" rowspan="1" colspan="1">c.349T&gt;C</td>
              <td align="left" rowspan="1" colspan="1">p.(Cys117Arg)</td>
              <td align="center" rowspan="1" colspan="1">6</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1">ClinVar Allele ID: 15917</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 2</td>
              <td align="left" rowspan="1" colspan="1">c.384_386del</td>
              <td align="left" rowspan="1" colspan="1">p.(Leu129del)</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1">ClinVar Allele ID: 106583</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 2</td>
              <td align="left" rowspan="1" colspan="1">c.395T&gt;C</td>
              <td align="left" rowspan="1" colspan="1">p.(Leu132Pro)</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 2</td>
              <td align="left" rowspan="1" colspan="1">c.427del</td>
              <td align="left" rowspan="1" colspan="1">p.(Val143Serfs*41)</td>
              <td align="center" rowspan="1" colspan="1">12</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1">rs746206847</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 2</td>
              <td align="left" rowspan="1" colspan="1">c.430G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Gly144Arg)</td>
              <td align="center" rowspan="1" colspan="1">8</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 2</td>
              <td align="left" rowspan="1" colspan="1">c.437G&gt;C</td>
              <td align="left" rowspan="1" colspan="1">p.(Trp146Ser)</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 2</td>
              <td align="left" rowspan="1" colspan="1">c.438G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Trp146*)</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 2</td>
              <td align="left" rowspan="1" colspan="1">c.440A&gt;C</td>
              <td align="left" rowspan="1" colspan="1">p.(His147Pro)</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 2</td>
              <td align="left" rowspan="1" colspan="1">c.454C&gt;T</td>
              <td align="left" rowspan="1" colspan="1">p.(Arg152Trp)</td>
              <td align="center" rowspan="1" colspan="1">62</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 2</td>
              <td align="left" rowspan="1" colspan="1">c.464G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Cys155Tyr)</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 2</td>
              <td align="left" rowspan="1" colspan="1">c.478C&gt;T</td>
              <td align="left" rowspan="1" colspan="1">p.(Arg160*)</td>
              <td align="center" rowspan="1" colspan="1">16</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 2</td>
              <td align="left" rowspan="1" colspan="1">c.479G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Arg160Gln)</td>
              <td align="center" rowspan="1" colspan="1">13</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 2</td>
              <td align="left" rowspan="1" colspan="1">c.499G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Gly167Arg)</td>
              <td align="center" rowspan="1" colspan="1">5</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 3</td>
              <td align="left" rowspan="1" colspan="1">c.511G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Gly171Ser)</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 3</td>
              <td align="left" rowspan="1" colspan="1">c.533A&gt;T</td>
              <td align="left" rowspan="1" colspan="1">p.(His178Leu)</td>
              <td align="center" rowspan="1" colspan="1">29</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 3</td>
              <td align="left" rowspan="1" colspan="1">c.571C&gt;T</td>
              <td align="left" rowspan="1" colspan="1">p.(Arg191*)</td>
              <td align="center" rowspan="1" colspan="1">7</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 3</td>
              <td align="left" rowspan="1" colspan="1">c.574T&gt;C</td>
              <td align="left" rowspan="1" colspan="1">p.(Cys192Arg)</td>
              <td align="center" rowspan="1" colspan="1">15</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 3</td>
              <td align="left" rowspan="1" colspan="1">c.589C&gt;T</td>
              <td align="left" rowspan="1" colspan="1">p.(Arg197*)</td>
              <td align="center" rowspan="1" colspan="1">5</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1">rs118203943</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 3</td>
              <td align="left" rowspan="1" colspan="1">c.629A&gt;G</td>
              <td align="left" rowspan="1" colspan="1">p.(Tyr210Cys)</td>
              <td align="center" rowspan="1" colspan="1">46</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1">ClinVar Allele ID: 15924</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Intron 3</td>
              <td align="left" rowspan="1" colspan="1">c.691‐1G&gt;A</td>
              <td align="center" rowspan="1" colspan="1">—</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1">rs6870443</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 4</td>
              <td align="left" rowspan="1" colspan="1">c.707T&gt;C</td>
              <td align="left" rowspan="1" colspan="1">p.(Leu236Pro)</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1">ClinVar Allele ID: 15918</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 4</td>
              <td align="left" rowspan="1" colspan="1">c.710C&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Ala237Asp)</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="left" rowspan="1" colspan="1">Likely benign</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 4</td>
              <td align="left" rowspan="1" colspan="1">c.716A&gt;G</td>
              <td align="left" rowspan="1" colspan="1">p.(Gln239Arg)</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 4</td>
              <td align="left" rowspan="1" colspan="1">c.753C&gt;G</td>
              <td align="left" rowspan="1" colspan="1">p.(Tyr251*)</td>
              <td align="center" rowspan="1" colspan="1">43</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 4</td>
              <td align="left" rowspan="1" colspan="1">c.765T&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Tyr255*)</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1">rs749015246</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 4</td>
              <td align="left" rowspan="1" colspan="1">c.797A&gt;C</td>
              <td align="left" rowspan="1" colspan="1">p.(Tyr266Ser)</td>
              <td align="center" rowspan="1" colspan="1">7</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 5<xref ref-type="fn" rid="humu23613-tbl2-note-0002">a</xref>
</td>
              <td align="left" rowspan="1" colspan="1">c.(898+1_899‐1)_(1142+1_1143‐1)del</td>
              <td align="center" rowspan="1" colspan="1">—</td>
              <td align="center" rowspan="1" colspan="1">6</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 5</td>
              <td align="left" rowspan="1" colspan="1">c.899‐1341_1142+1051del</td>
              <td align="center" rowspan="1" colspan="1">—</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 5</td>
              <td align="left" rowspan="1" colspan="1">c.903C&gt;G</td>
              <td align="left" rowspan="1" colspan="1">p.(Asn301Lys)</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1">rs779378413</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 5</td>
              <td align="left" rowspan="1" colspan="1">c.904G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Gly302Arg)</td>
              <td align="center" rowspan="1" colspan="1">10</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 5</td>
              <td align="left" rowspan="1" colspan="1">c.908G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Gly303Glu)</td>
              <td align="center" rowspan="1" colspan="1">5</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 5</td>
              <td align="left" rowspan="1" colspan="1">c.937C&gt;G</td>
              <td align="left" rowspan="1" colspan="1">p.(Pro313Ala)</td>
              <td align="center" rowspan="1" colspan="1">11</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 5</td>
              <td align="left" rowspan="1" colspan="1">c.943C&gt;T</td>
              <td align="left" rowspan="1" colspan="1">p.(Arg315*)</td>
              <td align="center" rowspan="1" colspan="1">10</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1">rs727503809</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 5</td>
              <td align="left" rowspan="1" colspan="1">c.944G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Arg315Gln)</td>
              <td align="center" rowspan="1" colspan="1">22</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1">ClinVar Allele ID: 177363</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 5</td>
              <td align="left" rowspan="1" colspan="1">c.960C&gt;G</td>
              <td align="left" rowspan="1" colspan="1">p.(Ser320Arg)</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 5</td>
              <td align="left" rowspan="1" colspan="1">c.962T&gt;C</td>
              <td align="left" rowspan="1" colspan="1">p.(Leu321Pro)</td>
              <td align="center" rowspan="1" colspan="1">60</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 5</td>
              <td align="left" rowspan="1" colspan="1">c.966G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Trp322*)</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1">rs398123125</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 5</td>
              <td align="left" rowspan="1" colspan="1">c.971G&gt;T</td>
              <td align="left" rowspan="1" colspan="1">p.(Gly324Val)</td>
              <td align="center" rowspan="1" colspan="1">5</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1">ClinVar Allele ID: 98267; rs773492223</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 5</td>
              <td align="left" rowspan="1" colspan="1">c.979C&gt;T</td>
              <td align="left" rowspan="1" colspan="1">p.(Arg327*)</td>
              <td align="center" rowspan="1" colspan="1">16</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1">rs201168448</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 5</td>
              <td align="left" rowspan="1" colspan="1">c.1001G&gt;T</td>
              <td align="left" rowspan="1" colspan="1">p.(Ser334Ile)</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 5</td>
              <td align="left" rowspan="1" colspan="1">c.1036del</td>
              <td align="left" rowspan="1" colspan="1">p.(Glu346Serfs*11)</td>
              <td align="center" rowspan="1" colspan="1">13</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 5</td>
              <td align="left" rowspan="1" colspan="1">c.1057T&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Trp353Arg)</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 5</td>
              <td align="left" rowspan="1" colspan="1">c.1079T&gt;C</td>
              <td align="left" rowspan="1" colspan="1">p.(Leu360Pro)</td>
              <td align="center" rowspan="1" colspan="1">6</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 5</td>
              <td align="left" rowspan="1" colspan="1">c.1127T&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Val376Glu)</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 5</td>
              <td align="left" rowspan="1" colspan="1">c.1142+2T&gt;A</td>
              <td align="center" rowspan="1" colspan="1">—</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 5</td>
              <td align="left" rowspan="1" colspan="1">c.1142+2T&gt;C</td>
              <td align="center" rowspan="1" colspan="1">—</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Intron 5</td>
              <td align="left" rowspan="1" colspan="1">c.1143‐1G&gt;C</td>
              <td align="center" rowspan="1" colspan="1">—</td>
              <td align="center" rowspan="1" colspan="1">16</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1">ClinVar Allele ID: 15926</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Intron 5</td>
              <td align="left" rowspan="1" colspan="1">c.1143‐8T&gt;G</td>
              <td align="center" rowspan="1" colspan="1">—</td>
              <td align="center" rowspan="1" colspan="1">24</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1">ClinVar Allele ID: 15927; rs431905496</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 6</td>
              <td align="left" rowspan="1" colspan="1">c.1151G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Ser384Asn)</td>
              <td align="center" rowspan="1" colspan="1">9</td>
              <td align="left" rowspan="1" colspan="1">Benign</td>
              <td align="left" rowspan="1" colspan="1">ClinVar Allele ID: 98263; rs25414</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 6</td>
              <td align="left" rowspan="1" colspan="1">c.1168G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Glu390Lys)</td>
              <td align="center" rowspan="1" colspan="1">6</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 6</td>
              <td align="left" rowspan="1" colspan="1">c.1178A&gt;C</td>
              <td align="left" rowspan="1" colspan="1">p.(His393Pro)</td>
              <td align="center" rowspan="1" colspan="1">10</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1">ClinVar Allele ID: 15925</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 6</td>
              <td align="left" rowspan="1" colspan="1">c.1178A&gt;G</td>
              <td align="left" rowspan="1" colspan="1">p.(His393Arg)</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 6</td>
              <td align="left" rowspan="1" colspan="1">c.1197C&gt;G</td>
              <td align="left" rowspan="1" colspan="1">p.(Phe399Leu)</td>
              <td align="center" rowspan="1" colspan="1">17</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1">rs200793396</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Intron 6</td>
              <td align="left" rowspan="1" colspan="1">c.1213+5G&gt;A</td>
              <td align="center" rowspan="1" colspan="1">—</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Intron 6</td>
              <td align="left" rowspan="1" colspan="1">c.1213+6T&gt;C</td>
              <td align="center" rowspan="1" colspan="1">—</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 7</td>
              <td align="left" rowspan="1" colspan="1">c.1214G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Cys405Tyr)</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1">ClinVar Allele ID: 15919; rs118203941</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 7</td>
              <td align="left" rowspan="1" colspan="1">c.1289A&gt;G</td>
              <td align="left" rowspan="1" colspan="1">p.(His430Arg)</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 7</td>
              <td align="left" rowspan="1" colspan="1">c.1325C&gt;T</td>
              <td align="left" rowspan="1" colspan="1">p.(Thr442Met)</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1">ClinVar Allele ID: 368534</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 7</td>
              <td align="left" rowspan="1" colspan="1">c.1336G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Gly446Ser)</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Intron 7</td>
              <td align="left" rowspan="1" colspan="1">c.1336+2T&gt;G</td>
              <td align="center" rowspan="1" colspan="1">—</td>
              <td align="center" rowspan="1" colspan="1">7</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1">rs768012515</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 8</td>
              <td align="left" rowspan="1" colspan="1">c.1340G&gt;T</td>
              <td align="left" rowspan="1" colspan="1">p.(Cys447Phe)</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 8</td>
              <td align="left" rowspan="1" colspan="1">c.1350G&gt;C</td>
              <td align="left" rowspan="1" colspan="1">p.(Trp450Cys)</td>
              <td align="center" rowspan="1" colspan="1">11</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1">rs555785323</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 8</td>
              <td align="left" rowspan="1" colspan="1">c.1366C&gt;T</td>
              <td align="left" rowspan="1" colspan="1">p.(Gln456*)</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1">rs200188234</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 8</td>
              <td align="left" rowspan="1" colspan="1">c.1415T&gt;C</td>
              <td align="left" rowspan="1" colspan="1">p. (Leu472Pro)</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">Likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 8</td>
              <td align="left" rowspan="1" colspan="1">c.1450A&gt;G</td>
              <td align="left" rowspan="1" colspan="1">p.(Arg484Gly)</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1">ClinVar Allele ID: 187113</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 8</td>
              <td align="left" rowspan="1" colspan="1">c.1457A&gt;T</td>
              <td align="left" rowspan="1" colspan="1">p.(Asp486Val)</td>
              <td align="center" rowspan="1" colspan="1">6</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 8</td>
              <td align="left" rowspan="1" colspan="1">c.1534_1556del</td>
              <td align="left" rowspan="1" colspan="1">p.(Val512Profs*3)</td>
              <td align="center" rowspan="1" colspan="1">13</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 8</td>
              <td align="left" rowspan="1" colspan="1">c.1562G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Cys521Tyr)</td>
              <td align="center" rowspan="1" colspan="1">9</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 8</td>
              <td align="left" rowspan="1" colspan="1">c.1577del</td>
              <td align="left" rowspan="1" colspan="1">p.(Thr526Metfs*48)</td>
              <td align="center" rowspan="1" colspan="1">8</td>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exon 8</td>
              <td align="left" rowspan="1" colspan="1">c.1582_1596del</td>
              <td align="left" rowspan="1" colspan="1">p.(Val528_Trp532del)</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1"> </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="humu23613-tbl2-note-0001">
            <p>Variants classified per Richards et al. (<xref rid="humu23613-bib-0089" ref-type="ref">2015</xref>). ClinVar accessed 06/05/2017.</p>
          </fn>
          <fn id="humu23613-tbl2-note-0002">
            <label>a</label>
            <p>Deletion of exon 5 without defined boundaries.</p>
          </fn>
        </table-wrap-foot>
        <permissions>
          <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
        </permissions>
      </table-wrap>
      <p>Individual characteristics of the patients were highly variable, highlighting the clinical heterogeneity of MPS VI. Patients displayed a wide range of clinical manifestations, ages at diagnosis, and national/geographic and ethnic backgrounds. Of the identified individuals, 54.8% (262/478) were homozygous for pathogenic <italic>ARSB</italic> variants, 35.6% (170/478) were heterozygous, 9.2% (44/478) had only one allele reported, and two individuals (0.4%) had both alleles unidentified. For alleles not characterized, we considered also those alleles carrying a polymorphism erroneously considered a disease‐causing variant. Patient gender was reported in 40% (190/478) of individuals and was split roughly evenly between genders (55% male; 45% female). Age at diagnosis (reported in 172 individuals) ranged from &lt;1 year to 45 years of age, with a mean of 7.8 years and median of 5.0 years. Two patients, both with an older affected sibling, were diagnosed at birth (Furujo, Kubo, Kosuga, &amp; Okuyama, <xref rid="humu23613-bib-0025" ref-type="ref">2011</xref>; Mendelsohn et al., <xref rid="humu23613-bib-0076" ref-type="ref">2013</xref>). Approximately one‐third (31.7%) of unique variants appeared only once in the population assessed, with an additional 28.5% appearing twice.</p>
      <p>In agreement with previous reports (Karageorgos et al., <xref rid="humu23613-bib-0057" ref-type="ref">2007b</xref>), most unique variants were missense (59.5%); followed by small deletions (13.5%), nonsense (12.0%), splice site or intronic variants (5.0%), small duplications (3.0%), and large deletions (3.0%) (Figure <xref rid="humu23613-fig-0001" ref-type="fig">1</xref>). Stop‐loss mutations were identified in 1.0% of variants.</p>
      <fig fig-type="Figure" xml:lang="en" id="humu23613-fig-0001" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Unique non‐polymorphic <italic>ARSB</italic> variants classified by mutation type, most common being missense and small deletion (<italic>N</italic> = 198 variants)</p>
        </caption>
        <graphic id="nlm-graphic-3" xlink:href="HUMU-39-1788-g001"/>
      </fig>
      <p>Commonly reported variants occur throughout the length of the <italic>ARSB</italic> gene, and include missense, nonsense, deletion, and intronic alleles (Figure <xref rid="humu23613-fig-0002" ref-type="fig">2</xref>). Only two alleles were reported more than 50 times in our sample taken globally: c.962T&gt;C [p.(Leu321Pro)] and c.454C&gt;T [p.(Arg152Trp)] (Table <xref rid="humu23613-tbl-0002" ref-type="table">2</xref>). These alleles are located in exons 5 and 2, respectively.</p>
      <fig fig-type="Figure" xml:lang="en" id="humu23613-fig-0002" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <p><italic>ARSB</italic> gene structure including coding variants reported &gt;5 times</p>
          <p>Location of selected MPS VI variants in the human <italic>ARSB</italic> gene and ASB peptide. Exons are represented by grey boxes; cDNA coordinates are indicated within the exons. ASB protein domains are color coded as shown by legend. Individual variants are color coded by mutation type</p>
        </caption>
        <graphic id="nlm-graphic-5" xlink:href="HUMU-39-1788-g002"/>
      </fig>
      <p>The most commonly described nonsense allele, c.979C&gt;T [p.(Arg327*)], was reported 16 times (1.8%) in our sample, and is expected to result in premature truncation of <italic>ARSB</italic> midway through exon 5. c.979C&gt;T is identified in various populations, including individuals from North and South America, Europe, and Asia, and was detected in a homozygous state in five individuals (5 of 11, 45.5%).</p>
      <p>The missense mutation c.284G&gt;A [p.(Arg95Gln)] is present in six individuals in our sample, but never in the homozygous state. Of note, Arg95 is the final residue making up the N‐terminal sulfatase domain (CTPSR sequence), which is conserved in several sulfatases including human arylsulfatase A, human steroid sulfatase, and sea urchin arylsulfatase (Peters et al., <xref rid="humu23613-bib-0084" ref-type="ref">1990</xref>). Individuals with this variant vary in phenotypic severity, presumably based on the allele present in the other <italic>ARSB</italic> parental allele.</p>
      <p>Three large deletions within the alkaline phosphatase‐like domain have also been reported. One large deletion that includes exons 2 and 3 was identified in homozygosity in a male Chinese individual with a classical, rapidly progressing MPS VI phenotype (Zheng et al., <xref rid="humu23613-bib-0117" ref-type="ref">2014</xref>); also a 13.8 kb deletion encompassing exons 2 and 3, whose breakpoints were defined, was reported in homozygosity in a boy with disease onset at 3 years (Ittiwut et al., <xref rid="humu23613-bib-0042" ref-type="ref">2017</xref>). A deletion of exon 4 [c.(690+1_691‐1)_(898+1_899‐1)del; breakpoints unknown] in its entirety was reported in homozygosity in one female Taiwanese individual. This deletion is expected to result in frameshift, premature truncation, and loss of significant portions of the catalytic domain (Lin, Ke, Chou, Wang, &amp; Tsai, <xref rid="humu23613-bib-0063" ref-type="ref">2015</xref>). Finally, a genomic deletion of exon 5 [c.(898+1_899‐1)_(1142+1_1143‐1)del] was reported eight times, once in homozygosity in a male Italian individual, who displayed a classical, severe MPS VI phenotype (Ferla et al., <xref rid="humu23613-bib-0022" ref-type="ref">2015</xref>). In only one case, the boundaries were defined (Villani et al., <xref rid="humu23613-bib-0104" ref-type="ref">2010</xref>).</p>
    </sec>
    <sec id="humu23613-sec-0060">
      <label>3.2</label>
      <title>Most common alleles</title>
      <p>Of the 12 most commonly reported alleles, 7 of these are missense mutations, 3 are nonsense mutations, and 2 are intronic/splice site mutations. The seven most commonly reported alleles (c.454C&gt;T, c.962T&gt;C, c.629A&gt;G, c.753C&gt;G, c.533A&gt;T, c.1143‐8T&gt;G, c.944G&gt;A) make up 31.5% of all alleles reported. Together, the three most frequently reported alleles make up 18.5% of all alleles reported (Table <xref rid="humu23613-tbl-0003" ref-type="table">3</xref>). Importantly, the allele frequency reported here may not represent the real‐world distribution of alleles, as well‐characterized alleles are less likely to be published and therefore may be underrepresented in the literature.</p>
      <table-wrap id="humu23613-tbl-0003" xml:lang="en" orientation="portrait" position="float">
        <label>Table 3</label>
        <caption>
          <p>Most common <italic>ARSB</italic> pathogenic and likely pathogenic variants reported in the assessed population<xref ref-type="fn" rid="humu23613-tbl3-note-0002">a</xref>
</p>
        </caption>
        <table frame="hsides" rules="groups">
          <col align="left" span="1"/>
          <col align="left" span="1"/>
          <col align="left" span="1"/>
          <thead>
            <tr style="border-bottom:solid 1px #000000">
              <th align="left" rowspan="1" colspan="1">Nucleotide Change</th>
              <th align="left" rowspan="1" colspan="1">Amino Acid Change</th>
              <th align="left" rowspan="1" colspan="1">Times Reported, <italic>n</italic> (%) <italic>N</italic> = 908 alleles</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">c.454C&gt;T</td>
              <td align="left" rowspan="1" colspan="1">p.(Arg152Trp)</td>
              <td align="left" rowspan="1" colspan="1">62 (6.8)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">c.962T&gt;C</td>
              <td align="left" rowspan="1" colspan="1">p.(Leu321Pro)</td>
              <td align="left" rowspan="1" colspan="1">60 (6.6)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">c.629A&gt;G</td>
              <td align="left" rowspan="1" colspan="1">p.(Tyr210Cys)</td>
              <td align="left" rowspan="1" colspan="1">46 (5.1)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">c.753C&gt;G</td>
              <td align="left" rowspan="1" colspan="1">p.(Tyr251<sup>*</sup>)</td>
              <td align="left" rowspan="1" colspan="1">43 (4.7)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">c.533A&gt;T</td>
              <td align="left" rowspan="1" colspan="1">p.(His178Leu)</td>
              <td align="left" rowspan="1" colspan="1">29 (3.2)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">c.1143‐8T&gt;G</td>
              <td align="center" rowspan="1" colspan="1">—</td>
              <td align="left" rowspan="1" colspan="1">24 (2.6)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">c.944G&gt;A</td>
              <td align="left" rowspan="1" colspan="1">p.(Arg315Gln)</td>
              <td align="left" rowspan="1" colspan="1">22 (2.4)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">c.1197C&gt;G</td>
              <td align="left" rowspan="1" colspan="1">p.(Phe399Leu)</td>
              <td align="left" rowspan="1" colspan="1">17 (1.9)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">c.1143‐1G&gt;C</td>
              <td align="center" rowspan="1" colspan="1">—</td>
              <td align="left" rowspan="1" colspan="1">16 (1.8)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">c.478C&gt;T</td>
              <td align="left" rowspan="1" colspan="1">p.(Arg160<sup>*</sup>)</td>
              <td align="left" rowspan="1" colspan="1">16 (1.8)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">c.979C&gt;T</td>
              <td align="left" rowspan="1" colspan="1">p.(Arg327<sup>*</sup>)</td>
              <td align="left" rowspan="1" colspan="1">16 (1.8)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">c.574T&gt;C</td>
              <td align="left" rowspan="1" colspan="1">p.(Cys192Arg)</td>
              <td align="left" rowspan="1" colspan="1">15 (1.7)</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="humu23613-tbl3-note-0001">
            <p>Nucleotide changes are per NM_0000446.4; protein changes are per NP_000037.2.</p>
          </fn>
          <fn id="humu23613-tbl3-note-0002">
            <label>a</label>
            <p>As it is uncommon to publish findings of well‐characterized alleles, these alleles may be underrepresented in the literature.</p>
          </fn>
        </table-wrap-foot>
        <permissions>
          <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
        </permissions>
      </table-wrap>
    </sec>
    <sec id="humu23613-sec-0070">
      <label>3.3</label>
      <title>Geographic distribution</title>
      <p>Information regarding ethnic or national origin was available for 406 individuals (85% of sample), and individuals from Africa, Asia, Australia, Europe, North America, and South America were included, although most of them came from the northern hemisphere. Allelic heterogeneity varied among individual populations, although rare or private mutations were prominent in all populations studied. Individuals from Italy, the United States, and Colombia were the most genetically heterogeneous, with the largest proportion of rare or private mutations (≈84% of individuals) in the populations studied (Figure <xref rid="humu23613-fig-0003" ref-type="fig">3</xref>).</p>
      <fig fig-type="Figure" xml:lang="en" id="humu23613-fig-0003" orientation="portrait" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Most common alleles for the 10 most frequent nationalities/ethnic backgrounds reported. The number of times an allele was encountered in a population is shown in parentheses. In grey other variants, reported less or equal to 5 times</p>
        </caption>
        <graphic id="nlm-graphic-7" xlink:href="HUMU-39-1788-g003"/>
      </fig>
      <p>Turkey was the most heavily represented national origin, with information reported for 55 Turkish individuals (13.5% of total reported). Of the major populations studied, the Turkish population was the most genetically homogenous, and 54 of 55 Turkish individuals were homozygous. Variant p.(Leu321Pro) accounted for nearly half of all alleles reported in Turkish individuals (50/110). c.1036del was heavily represented in this population. Interestingly, p.(Leu321Pro) did not appear to be associated with a phenotypic signature in this population, possibly due to the relatively high rates of consanguineous marriages in Turkey, leading to a higher proportion of homozygous alleles across the genome and variable clinical phenotypes (Koc, <xref rid="humu23613-bib-0059" ref-type="ref">2008</xref>; Zanetti et al., <xref rid="humu23613-bib-0115" ref-type="ref">2014</xref>).</p>
      <p>Mutations in Trp450 [p.(Trp450Cys) and p.(Trp450Leu)] were found exclusively in individuals from India, and resulted in a range of clinical phenotypes. Variant p.(Phe399Leu) (c.1197C&gt;G) was commonly reported in individuals from both China (59% of individuals) and Taiwan (38% of individuals), and was associated with a classical phenotype in these patients.</p>
    </sec>
    <sec id="humu23613-sec-0080">
      <label>3.4</label>
      <title>ASB structure and variants of special interest</title>
      <p>Arylsulfatase B includes two domains; a larger N‐terminal domain and a smaller C‐terminal domain; and reported to function as a monomer (Mathew et al., <xref rid="humu23613-bib-0071" ref-type="ref">2015</xref>; McGovern, Vine, Haskins, &amp; Desnick, <xref rid="humu23613-bib-0073" ref-type="ref">1982</xref>). ASB contains two conserved sulfatase regions near the N‐terminal (Bond et al., <xref rid="humu23613-bib-0006" ref-type="ref">1997</xref>; Peters et al., <xref rid="humu23613-bib-0084" ref-type="ref">1990</xref>). The active site pocket is located near the surface of the folded enzyme, and consists of Asp53, Asp54, Cys91, Pro93, Ser94, Arg95, Lys145, His147, His242, Asp300, and Lys318. A cluster of conserved cysteine residues is also thought to be required for enzymatic activity (Bond et al., <xref rid="humu23613-bib-0006" ref-type="ref">1997</xref>; Brooks et al., <xref rid="humu23613-bib-0010" ref-type="ref">1995</xref>).</p>
      <p>Pathogenic variants in <italic>ARSB</italic> do not appear to be concentrated in any particular region or domain of the ASB protein. Although pathogenic variants in or near the active site pocket were identified, many are located remotely from the active site (Figure <xref rid="humu23613-fig-0004" ref-type="fig">4</xref>). Importantly, genotype–phenotype correlations in MPS VI have remained elusive, due (at least in part) to the large proportion of rare or private <italic>ARSB</italic> mutations, limited phenotypic reporting, and overall heterogeneity of the disease (Vairo et al., <xref rid="humu23613-bib-0099" ref-type="ref">2015</xref>; Valayannopoulos et al., <xref rid="humu23613-bib-0100" ref-type="ref">2010</xref>). This is especially true for missense mutations, whose effect on ASB enzyme function may not be immediately apparent (Valayannopoulos et al., <xref rid="humu23613-bib-0100" ref-type="ref">2010</xref>). In addition, residual ASB enzyme activity does not clearly correlate with the severity of clinical phenotype in patients with MPS VI. While detailed structural analysis or genotype–phenotype correlation are beyond the scope of this publication, our observations mentioned previously are generally consistent with previous reports (e.g., Karageorgos et al., <xref rid="humu23613-bib-0056" ref-type="ref">2007a</xref>,<xref rid="humu23613-bib-0057" ref-type="ref">b</xref>; Lin et al., <xref rid="humu23613-bib-0064" ref-type="ref">2008</xref>; Saito, Ohno, Sugawara, &amp; Sakuraba, <xref rid="humu23613-bib-0090" ref-type="ref">2008</xref>).</p>
      <fig fig-type="Figure" xml:lang="en" id="humu23613-fig-0004" orientation="portrait" position="float">
        <label>Figure 4</label>
        <caption>
          <p>ASB structure and variants of special interest</p>
          <p>Three‐dimensional structure of mature human ASB protein overlaid with variants of interest. The enzyme active site pocket is indicated by colored space‐filling models</p>
        </caption>
        <graphic id="nlm-graphic-9" xlink:href="HUMU-39-1788-g004"/>
      </fig>
      <p>c.215T&gt;G [p.(Leu72Arg)] is associated with early onset and classical, rapidly progressing disease, consistent with a lack of detectable ASB protein and enzymatic activity when expressed in cultured fibroblasts (Karageorgos et al., <xref rid="humu23613-bib-0055" ref-type="ref">2004</xref>, <xref rid="humu23613-bib-0056" ref-type="ref">2007a</xref>,<xref rid="humu23613-bib-0057" ref-type="ref">b</xref>; Petry et al., <xref rid="humu23613-bib-0085" ref-type="ref">2005</xref>). Leu72 resides in the 3′ coil of ASB, and a leucine‐to‐arginine change is predicted to disrupt formation of this coil and result in severe disturbance of ASB structure (Karageorgos et al., <xref rid="humu23613-bib-0056" ref-type="ref">2007a</xref>). Of note, Leu72 is conserved in certain other sulfatases, including galactose‐3‐sulfatase (ASA) and <italic>N</italic>‐acetylgalactosamine‐6‐sulfatase (GALNS) (Bond et al., <xref rid="humu23613-bib-0006" ref-type="ref">1997</xref>).</p>
      <p>c.454C&gt;T [p.(Arg152Trp)] was the most frequently reported allele in our sample (62/916; 6.8%). p.(Arg152Trp) was detected in several distinct ethnic populations, including individuals from Turkey, Russia, Northern Europe, Western Europe, and Eastern Europe, where specifically it is thought to be a founder mutation (Chistiakov et al., <xref rid="humu23613-bib-0013" ref-type="ref">2014</xref>; Jurecka et al., <xref rid="humu23613-bib-0047" ref-type="ref">2012a</xref>). p.(Arg152Trp) has been identified in both heterozygous and homozygous states, and is associated with non‐classical, slowly progressing phenotypes in homozygotes, with some patients living into their thirties (Brands et al., <xref rid="humu23613-bib-0008" ref-type="ref">2013a</xref>; Chistiakov et al., <xref rid="humu23613-bib-0013" ref-type="ref">2014</xref>; Ferla et al., <xref rid="humu23613-bib-0022" ref-type="ref">2015</xref>; Jurecka et al., <xref rid="humu23613-bib-0046" ref-type="ref">2011b</xref>, <xref rid="humu23613-bib-0047" ref-type="ref">2012a</xref>; Karageorgos et al., <xref rid="humu23613-bib-0057" ref-type="ref">2007b</xref>; Thümler et al., <xref rid="humu23613-bib-0096" ref-type="ref">2012</xref>). Interestingly, p.(Arg152Trp) has been associated with a primarily cardiac and musculoskeletal phenotype in certain patients, but whether this indicates a genuine genotype–phenotype correlation remains unclear (Brands et al., <xref rid="humu23613-bib-0008" ref-type="ref">2013a</xref>; Jurecka et al., <xref rid="humu23613-bib-0045" ref-type="ref">2011a</xref>). Trp152 is located near the conserved hexapeptide sequence 144‐Gly‐Lys‐Trp‐His‐Leu‐Gly‐149, the largest connecting stretch of identity between arylsulfatases (Peters et al., <xref rid="humu23613-bib-0084" ref-type="ref">1990</xref>; Voskoboeva, Isbrandt, von Figura, Krasnopolskaya, &amp; Peters, <xref rid="humu23613-bib-0105" ref-type="ref">1994</xref>).</p>
      <p>c.479G&gt;A [p.(Arg160Gln)] results from a transition in a CpG dinucleotide (Litjens &amp; Hopwood, <xref rid="humu23613-bib-0068" ref-type="ref">2001</xref>). p.(Arg160Gln) has been observed in both heterozygous and homozygous states (Kantaputra et al., <xref rid="humu23613-bib-0054" ref-type="ref">2014</xref>; Mathew et al., <xref rid="humu23613-bib-0071" ref-type="ref">2015</xref>; Villani et al., <xref rid="humu23613-bib-0104" ref-type="ref">2010</xref>; Voskoboeva et al., <xref rid="humu23613-bib-0105" ref-type="ref">1994</xref>). The mechanism by which the arginine‐to‐glutamine alteration contributes to disease is not well understood, as its effect on enzyme structure is predicted to be minimal (Mathew et al., <xref rid="humu23613-bib-0071" ref-type="ref">2015</xref>). However, Arg160 immediately precedes the dipeptide sequence 161‐Gly‐Phe‐162, which is conserved in arylsulfatases (Peters et al., <xref rid="humu23613-bib-0084" ref-type="ref">1990</xref>; Voskoboeva et al., <xref rid="humu23613-bib-0105" ref-type="ref">1994</xref>). Interestingly, wild‐type arylsulfatase A (ASA) also contains a glutamine in the position immediately preceding the conserved dipeptide sequence (Peters et al., <xref rid="humu23613-bib-0084" ref-type="ref">1990</xref>).</p>
      <p>Of note, a nonsense mutation [p.(Arg160*)] has also been identified at Arg160, and thus Arg160 has been suggested to be a mutational hot spot in the <italic>ARSB</italic> gene (Kantaputra et al., <xref rid="humu23613-bib-0054" ref-type="ref">2014</xref>; Voskoboeva et al., <xref rid="humu23613-bib-0105" ref-type="ref">1994</xref>). Further supporting this idea is the observation that Arg160 mutations have been found in diverse populations and ethnic groups, including patients of Belarusian, German, Indian, Italian, Russian, Spanish, and Taiwanese descent (Garrido et al., <xref rid="humu23613-bib-0027" ref-type="ref">2007</xref>; Jurecka et al., <xref rid="humu23613-bib-0047" ref-type="ref">2012a</xref>; Kantaputra et al., <xref rid="humu23613-bib-0054" ref-type="ref">2014</xref>; Thümler et al., <xref rid="humu23613-bib-0096" ref-type="ref">2012</xref>; Voskoboeva et al., <xref rid="humu23613-bib-0105" ref-type="ref">1994</xref>).</p>
      <p>c.629A&gt;G [p.(Tyr210Cys)], previously reported as the most common pathogenic variant in patients with MPS VI (Karageorgos et al., <xref rid="humu23613-bib-0057" ref-type="ref">2007b</xref>), was the third most frequently reported allele (49/916, 5.3%) in this analysis, found in 11.1% of individuals collected. Individuals with the p.(Tyr210Cys) mutation spanned several ethnic populations, including individuals from Australia and Western Europe. Previous work from Bradford, Litjens, Parkinson, Hopwood, and Brooks (<xref rid="humu23613-bib-0007" ref-type="ref">2002</xref>) has demonstrated that the substitution of Tyr210 with cysteine causes impaired protein processing, trafficking, and instability of the mutant ASB protein, ultimately leading to decreased levels of mature, functional protein in lysosomes. Tyr210 is located between the sixth beta‐strand and fifth alpha‐helix of ASB (Saito et al., <xref rid="humu23613-bib-0090" ref-type="ref">2008</xref>). The tyrosine‐to‐cysteine change is predicted to result in a relatively stable enzyme which should retain some enzymatic activity (Saito et al., <xref rid="humu23613-bib-0090" ref-type="ref">2008</xref>). As such, patients with the p.(Tyr210Cys) mutation generally exhibit a non‐classical, slowly progressing form of MPS VI, and the p.(Tyr210Cys) mutation may reduce the severity of other <italic>ARSB</italic> pathogenic variants when present in a compound heterozygous state (Bradford et al., <xref rid="humu23613-bib-0007" ref-type="ref">2002</xref>; Brands et al., <xref rid="humu23613-bib-0008" ref-type="ref">2013a</xref>; Litjens, Brooks, Peters, Gibson, &amp; Hopwood, <xref rid="humu23613-bib-0067" ref-type="ref">1996</xref>; Saito et al., <xref rid="humu23613-bib-0090" ref-type="ref">2008</xref>). Interestingly, this allele has only been reported in a homozygous state twice (Gottwald et al., <xref rid="humu23613-bib-0030" ref-type="ref">2011</xref>; Mendelsohn et al., <xref rid="humu23613-bib-0076" ref-type="ref">2013</xref>), despite having a relatively high allele frequency reported in the Genome Aggregation Database (gnomAD; gnomad.broadinstitute.org, accessed October 26, 2017), a large population database. Both individuals had a non‐classical form of the disease (Gottwald et al., <xref rid="humu23613-bib-0030" ref-type="ref">2011</xref>; Mendelsohn et al., <xref rid="humu23613-bib-0076" ref-type="ref">2013</xref>).</p>
      <p>c.944G&gt;A [p.(Arg315Gln)] has been reported in both heterozygous and homozygous states (Petry et al., <xref rid="humu23613-bib-0085" ref-type="ref">2005</xref>; Villani et al., <xref rid="humu23613-bib-0103" ref-type="ref">1999</xref>). Patients with two p.(Arg315Gln) alleles demonstrate a range of clinical phenotypes, from intermediate to classically severe (Di Natale et al., <xref rid="humu23613-bib-0019" ref-type="ref">2008</xref>; Karageorgos et al., <xref rid="humu23613-bib-0057" ref-type="ref">2007b</xref>; Petry et al., <xref rid="humu23613-bib-0085" ref-type="ref">2005</xref>; Villani et al., <xref rid="humu23613-bib-0103" ref-type="ref">1999</xref>). Arg315 is predicted to form a salt bridge with Asp466, as well as hydrogen bonds with Gly448 and Glu483 (Garrido et al., <xref rid="humu23613-bib-0027" ref-type="ref">2007</xref>; Mathew et al., <xref rid="humu23613-bib-0071" ref-type="ref">2015</xref>). Thus, the arginine‐to‐glutamine alteration is predicted to hinder both substrate binding and metal ion coordination (Villani et al., <xref rid="humu23613-bib-0103" ref-type="ref">1999</xref>). Two additional mutations at Arg315 have also been reported—the missense mutation p.(Arg315Pro) and the nonsense mutation p.(Arg315*), which produces a polypeptide roughly one‐third the length of wild‐type and is predicted to lack enzymatic activity (Di Natale et al., <xref rid="humu23613-bib-0019" ref-type="ref">2008</xref>; Ferla et al., <xref rid="humu23613-bib-0022" ref-type="ref">2015</xref>; Lin et al., <xref rid="humu23613-bib-0064" ref-type="ref">2008</xref>; Mathew et al., <xref rid="humu23613-bib-0071" ref-type="ref">2015</xref>; Villani et al., <xref rid="humu23613-bib-0104" ref-type="ref">2010</xref>). Both p.(Arg315Gln) and p.(Arg315Pro) result from an alteration in the CpG dinucleotide c.944G, suggesting this nucleotide may be a mutational hot spot in <italic>ARSB</italic> (Litjens &amp; Hopwood, <xref rid="humu23613-bib-0068" ref-type="ref">2001</xref>; Mathew et al., <xref rid="humu23613-bib-0071" ref-type="ref">2015</xref>).</p>
      <p>c.962T&gt;C [p.(Leu321Pro)] was the second most common allele identified in the literature search (60/916; 6.6%). p.(Leu321Pro) was found primarily (but not exclusively) in patients of Turkish origin, where it is believed to be a founder mutation (Kantaputra et al., <xref rid="humu23613-bib-0054" ref-type="ref">2014</xref>). Interestingly, the c.962T&gt;C mutation is not found in gnomAD (gnomad.broadinstitute.org, accessed October 26, 2017), further supporting the hypothesis that this is primarily a population‐specific variant. Individuals homozygous for p.(Leu321Pro) demonstrated a range of clinical phenotypes, from a classic, rapidly progressing phenotype to a non‐classical, slowly progressing phenotype (Isbrandt et al., <xref rid="humu23613-bib-0040" ref-type="ref">1994</xref>; Kantaputra et al., <xref rid="humu23613-bib-0054" ref-type="ref">2014</xref>; Zanetti et al., <xref rid="humu23613-bib-0115" ref-type="ref">2014</xref>). Of note, Leu321 is not conserved between the arylsulfatases, and the effect of the p.(Leu321Pro) mutation on the secondary structure of ASB is not known (Isbrandt et al., <xref rid="humu23613-bib-0040" ref-type="ref">1994</xref>).</p>
      <p>c.1197C&gt;G [p.(Phe399Leu)] was observed solely in individuals from China and Taiwan, and was heavily represented in both populations. p.(Phe399Leu) was associated with a severe phenotype in homozygous individuals (Lin et al., <xref rid="humu23613-bib-0064" ref-type="ref">2008</xref>; Yang, Wu, Lin, &amp; Tsai, <xref rid="humu23613-bib-0113" ref-type="ref">2001</xref>; Zheng et al., <xref rid="humu23613-bib-0117" ref-type="ref">2014</xref>). One report suggests that the p.(Phe399Leu) allele may be associated with the polymorphisms c.1072G&gt;A and c.1191G&gt;A, and that these alleles may share a common origin (Lin et al., <xref rid="humu23613-bib-0064" ref-type="ref">2008</xref>).</p>
    </sec>
    <sec id="humu23613-sec-0090">
      <label>3.5</label>
      <title>Homozygosity</title>
      <p>Homozygote subjects are particularly represented in the analyzed population of MPS VI patients, 55% of all reported cases. Analysis of homozygotes may be useful for the <italic>in vivo</italic> genotype–phenotype correlation and also for the comprehension of the geographical distribution of the pathogenic variants. This analysis has identified 55 variants which were present in a homozygote condition only once; several other variants were present in the examined population 2–5 times. Only eight variants were present six or more times in homozygosis. Interestingly, these variants represent a particular geographical/ethnographical distribution, each being mostly present in only one ethnic group (<xref rid="humu23613-supl-0001" ref-type="supplementary-material">Supp. Mat. S4</xref>). Of the 30 homozygote subjects with the variant p.(Leu321Pro), 25 are of Turkish background. All 21 homozygote subjects with the p.(Tyr251*) variant are Arabic, and 11 of the 16 homozygote subjects with the p.(Arg152Trp) variant are from Russia or from Baltic countries. Lastly, all 14 homozygote subjects with the variant p.(His178Leu) are Brazilian, and belong to a cluster of MPS VI patients living in Northeast Brazil. These subjects all show the same haplotype (Costa‐Motta et al., <xref rid="humu23613-bib-0017" ref-type="ref">2014</xref>), which is likely due to a founder effect, with the contemporary presence of parental consanguinity and endogamy.</p>
      <p>Our analysis of the genotype–phenotype correlation based on homozygotes was poorly informative for most variants, except p.(Tyr251*), p.(Arg152Trp), and p.(Cys192Arg). Variant p.(Tyr251*) was associated with a severe phenotype in most subjects (17/21), p.(Arg152Trp) was associated with an attenuated phenotype in almost all subjects (14/15), and p.(Cys192Arg) was associated with an attenuated phenotype in half of the subjects reported (3/6).</p>
    </sec>
    <sec id="humu23613-sec-0100">
      <label>3.6</label>
      <title>Conflicting issues</title>
      <p>Two polymorphisms, or benign variants erroneously reported as disease‐causing variants, were collected in this review, despite only collecting variants reported as linked to disease. c.1151G&gt;A [p.(Ser384Asn)] and c.98C&gt;T [p.(Ala33Val)] are now known to be benign. These variants are highlighted in blue in <xref rid="humu23613-supl-0001" ref-type="supplementary-material">Supp. Mat. S3</xref>, and also reported in Supp. Mat. S2. Moreover, a list of variants in <italic>ARSB</italic> with frequency&gt;1% in gnomAD (gnomad.broadinstiture.org, accessed October 26, 2017) is reported in Supp. Mat. S5. As for variant c.1151G&gt;A [p.(Ser384Asn)], it has been determined to not be a disease‐causing variant a few years ago (Zanetti et al., <xref rid="humu23613-bib-0114" ref-type="ref">2009</xref>), but it had been reported as such in nine alleles in data collected from previously published literature.</p>
      <p>A re‐analysis of molecular data of the entire gene in those patients with only one allele identified, or with one allele carrying a known polymorphism, should be strongly encouraged, searching for potential missed variants such as large deletions, intronic or promotorial variants. On the contrary, all the synonymous variants encountered in our analysis [c.246G&gt;A, p.(Leu82Leu); p.(Ile114Ile); p.(Leu124Leu); c.1515C&gt;T, p.(Tyr505Tyr)] were considered polymorphisms. Actually these variants should be considered potentially pathogenetic, given their absence from gnomAD database, with the exception of p.(Leu82Leu) which has a frequency of 0.003858%. In fact, despite their name, synonymous or silent variants are no longer considered “neutral” variants with no functional consequences on protein, but are considered variants that may affect the function of translated protein through different cellular mechanisms (Hunt, Simhadri, Iandoli, Sauna, &amp; Kimchi‐Sarfaty, <xref rid="humu23613-bib-0039" ref-type="ref">2014</xref>). However, not enough information is available from the literature for the classification of these <italic>ARSB</italic> synonymous variants according to ACMG criteria, therefore in this study they are reported as with “not enough evidence.” Moreover, an underestimation of this kind of nucleotide substitution in our study has to be taken into account and, in light of this fact, a re‐evaluation of those patients missing the identification of one (or both) variant(s) or with one allele (or both alleles) carrying only a polymorphism should be performed, as mentioned above.</p>
    </sec>
    <sec id="humu23613-sec-0110">
      <label>3.7</label>
      <title>ACMG classification of ARSB variants</title>
      <p>A classification of <italic>ARSB</italic> sequence variants was performed according to ACMG criteria. This analysis evidenced that, for most variants (about 45%), there is not enough evidence in the literature for their classification, and thus they are variants of “uncertain significance.” The remaining variants were classified in “likely pathogenic” (37%) and “pathogenic” (16%). One variant (c.113_121del), despite having a frequency &lt; 1% (0.1719%) resulted “benign” using the ACMG approach. Hence, this in‐frame deletion seems to be a polymorphism, if we consider only the South Asian population in which it has a frequency of 1.37%.</p>
      <p>These results provide evidence for the need of a deeper analysis of the variants diagnosed in MPS VI patients: this should include both <italic>in vitro</italic> and <italic>in silico</italic> analysis. Moreover, specific attention has to be paid to the annotation of the variants: the use of the most updated gene variant nomenclature suggested by HGVS (v15.11) is recommended so as to use shared rules that could unequivocally describe a specific variant with no risk of misreporting.</p>
    </sec>
  </sec>
  <sec id="humu23613-sec-0120">
    <label>4</label>
    <title>CLINICAL RELEVANCE</title>
    <sec id="humu23613-sec-0130">
      <label>4.1</label>
      <title>Diagnostic strategies and complications</title>
      <p>Mucopolysaccharidoses, including MPS VI, are generally diagnosed by a combination of clinical findings and laboratory tests. Often, the first biochemical test performed upon clinical suspicion of MPS is the analysis of urinary glycosaminoglycans (uGAGs). While commonly used, a positive uGAG test is not sufficient for an MPS diagnosis, and a negative uGAG test is not sufficient to rule out a diagnosis of MPS (Cobos, Steglich, Santer, Lukacs, &amp; Gal, <xref rid="humu23613-bib-0014" ref-type="ref">2015</xref>; Vairo et al., <xref rid="humu23613-bib-0099" ref-type="ref">2015</xref>). Additionally, individuals with non‐classical MPS VI and/or older individuals with MPS VI may not show strong uGAG elevation (Wood et al., <xref rid="humu23613-bib-0110" ref-type="ref">2012</xref>). While tandem mass spectrometry‐based (MS/MS) testing of uGAGs appears to have increased sensitivity in these individuals, the MS/MS format of the uGAG test is not widely available. Due to the lack of MS/MS availability and the potential to misdiagnose MPS, a lysosomal enzyme panel is often preferable for MPS screening (Wood et al., <xref rid="humu23613-bib-0110" ref-type="ref">2012</xref>).</p>
      <p>When clinical suspicion for MPS is high (or after a finding of elevated uGAGs), individuals undergo testing for lysosomal enzyme activity via fibroblasts, leukocytes, or dried blood spots (DBS), which are commonly used due to their low cost, ease of collection, and simple storage requirements (Cobos et al., <xref rid="humu23613-bib-0014" ref-type="ref">2015</xref>; Vairo et al., <xref rid="humu23613-bib-0099" ref-type="ref">2015</xref>; Wood et al., <xref rid="humu23613-bib-0110" ref-type="ref">2012</xref>). Although enzyme activity varies among individuals (e.g., due to the specific <italic>ARSB</italic> variant, assay method, etc.), most individuals with MPS VI demonstrate ASB activity &lt;10% of the lower limit of normal level across the disease spectrum (Valayannopoulos et al., <xref rid="humu23613-bib-0100" ref-type="ref">2010</xref>).</p>
      <p>A confirmation of MPS VI diagnosis does require the specific pathogenic variants in <italic>ARSB</italic> to be determined. Moreover, variant identification is beneficial to individuals with MPS VI and their relatives as it can render genetic counseling possible and potentially inform treatment decisions. Although most genotype–phenotype correlations remain uncertain in MPS VI, some variants (e.g., large deletions, nonsense mutations, frameshift, and certain missense mutations) do appear to be correlated with a classic, rapidly progressing phenotype (Karageorgos et al., <xref rid="humu23613-bib-0057" ref-type="ref">2007b</xref>).</p>
      <p>Importantly, delays in diagnosis of MPS are quite common, especially in patients with non‐classical patterns of disease. These patients may present later in life without the typical physical features of MPS, resulting in a low‐clinical suspicion of disease and a delay to diagnosis (Fernández‐Marmiesse et al., <xref rid="humu23613-bib-0023" ref-type="ref">2014</xref>; Vairo et al., <xref rid="humu23613-bib-0099" ref-type="ref">2015</xref>). In addition, clinical features of many MPS overlap, making a specific diagnosis difficult based on clinical presentation alone. Finally, some attenuated patients may display a normal result on a urine GAG screen despite having disease‐causing variants and clinical symptoms of MPS (Fernández‐Marmiesse et al., <xref rid="humu23613-bib-0023" ref-type="ref">2014</xref>). This diagnostic delay is particularly troubling in MPS disorders where treatment options are available (as for MPS VI), as certain clinical manifestations may not be reversible once they arise.</p>
    </sec>
    <sec id="humu23613-sec-0140">
      <label>4.2</label>
      <title>Treatment options</title>
      <p>The primary goal of therapy in individuals with LSDs is to preserve or restore function by removing excess material accumulated in the lysosome and/or to prevent future buildup of substrate. While treatment options for certain LSDs are still limited, therapeutic options for MPS have advanced significantly over the past decade. Enzyme replacement therapy (ERT) is now available for four MPS disorders (MPS I, MPS II, MPS IVA, and MPS VI), and hematopoietic stem cell transplantation has demonstrated effectiveness in some patients (Biffi, <xref rid="humu23613-bib-0005" ref-type="ref">2017</xref>; Vairo et al., <xref rid="humu23613-bib-0099" ref-type="ref">2015</xref>; Valayannopoulos, <xref rid="humu23613-bib-0101" ref-type="ref">2013</xref>). In addition, novel therapeutic approaches are currently being studied for LSDs including gene therapy, substrate reduction therapy, and chemical chaperone therapy (Macauley, <xref rid="humu23613-bib-0070" ref-type="ref">2016</xref>; Rastall &amp; Amalfitano, <xref rid="humu23613-bib-0088" ref-type="ref">2015</xref>; Valayannopoulos, <xref rid="humu23613-bib-0101" ref-type="ref">2013</xref>).</p>
      <p>Since initial U.S. approval in 2005, ERT is available for patients with MPS VI in many countries (Naglazyme, BioMarin Pharmaceutical Inc., 2013). Galsulfase, a purified human enzyme, has been shown to improve walking capacity, stair‐climbing capacity, pulmonary function, hepatosplenomegaly, cardiac function, and survival in individuals with MPS VI (Giugliani et al., <xref rid="humu23613-bib-0031" ref-type="ref">2014</xref>; Harmatz et al., <xref rid="humu23613-bib-0032" ref-type="ref">2006</xref>, <xref rid="humu23613-bib-0033" ref-type="ref">2008</xref>, <xref rid="humu23613-bib-0034" ref-type="ref">2010</xref>, <xref rid="humu23613-bib-0035" ref-type="ref">2014</xref>; Naglazyme, BioMarin Pharmaceutical Inc., 2013; Quartel et al., <xref rid="humu23613-bib-0087" ref-type="ref">2018</xref>). As multiple studies have demonstrated that early intervention with ERT (before irreversible complications arise) is beneficial (Furujo et al., <xref rid="humu23613-bib-0025" ref-type="ref">2011</xref>; McGill et al., <xref rid="humu23613-bib-0072" ref-type="ref">2010</xref>; Meikle &amp; Hopwood, <xref rid="humu23613-bib-0075" ref-type="ref">2003</xref>; Muenzer, <xref rid="humu23613-bib-0078" ref-type="ref">2014</xref>; Wang et al., <xref rid="humu23613-bib-0108" ref-type="ref">2011</xref>), it is vital that diagnosis be made swiftly and accurately in order to maximize the therapeutic potential of ERT.</p>
    </sec>
  </sec>
  <sec id="humu23613-sec-0150">
    <label>5</label>
    <title>FUTURE PROSPECTS</title>
    <p>One potential remedy to delayed diagnosis is the wider adaptation of newborn screening, particularly in regions where MPS disorders are common, or prenatal screening when a family history of MPS is known (Wang et al., <xref rid="humu23613-bib-0108" ref-type="ref">2011</xref>). In fact, pilot programs of this nature are already underway in many regions of the world, including parts of Austria, Brazil, Mexico, Spain, Taiwan, and the United States, several of which have proven successful at identifying lysosomal storage disorders (including MPS) in newborns prior to the onset of clinical symptoms (Acosta, Abe‐Sandes, Giugliani, &amp; Bittles, <xref rid="humu23613-bib-0001" ref-type="ref">2013</xref>; Colón et al., <xref rid="humu23613-bib-0015" ref-type="ref">2017</xref>; Hopkins et al., <xref rid="humu23613-bib-0037" ref-type="ref">2015</xref>; Lin et al., <xref rid="humu23613-bib-0062" ref-type="ref">2013</xref>; Mechtler et al., <xref rid="humu23613-bib-0074" ref-type="ref">2012</xref>; Navarrete‐Martínez et al., <xref rid="humu23613-bib-0080" ref-type="ref">2017</xref>). While these types of screening programs can be somewhat costly and time‐consuming, the systematic reporting and classification of alleles has the potential to reduce ethical complications in cases where novel variants with unknown pathogenicity are identified (Wang et al., <xref rid="humu23613-bib-0108" ref-type="ref">2011</xref>).</p>
    <p>Another appealing option for diagnosis of MPS is next‐generation sequencing (NGS), a platform capable of performing the sequencing of multiple genes in a single reaction. NGS is currently the method of choice for gene panels, whole exome, and whole genome analyses, and is particularly powerful for pathogenic variant identification in disorders such as MPS VI which are rare, clinically heterogeneous, and demonstrate a large proportion of private mutations (Lohmann &amp; Klein, <xref rid="humu23613-bib-0069" ref-type="ref">2014</xref>). For example, whole exome sequencing (WES) was recently demonstrated to successfully diagnose a symptomatic patient with MPS IIIB, revealing compound heterozygous mutations, one of which was novel (Zeng et al., <xref rid="humu23613-bib-0116" ref-type="ref">2017</xref>). Although NGS is more expensive than other commonly used diagnostic techniques, the price has steadily decreased since the advent of NGS and will likely continue to do so, potentially allowing for more widespread use of NGS in practice (Lohmann &amp; Klein <xref rid="humu23613-bib-0069" ref-type="ref">2014</xref>; Vairo et al., <xref rid="humu23613-bib-0099" ref-type="ref">2015</xref>). In addition, a genetic diagnosis allows for genetic counseling and rapid treatment initiation, both of which are vital for patients with MPS and their families (Fernández‐Marmiesse et al., <xref rid="humu23613-bib-0023" ref-type="ref">2014</xref>). Of note, while NGS is promising, this technique could fail to detect certain pathogenic variants, including complete gene deletions and genetic inversions or rearrangements, potentially leading to false negatives in some cases (Vairo et al., <xref rid="humu23613-bib-0099" ref-type="ref">2015</xref>).</p>
    <p>Finally, increased reporting of pathogenic variants in <italic>ARSB</italic>, specifically in publicly available databases, coupled with a clinical description and other patient information may help to shorten the time for diagnosis, prevent misdiagnosis, and assist in understanding genotype–phenotype interactions where present. At present, variants can be submitted to, and reviewed at, the clinically‐focused, public database ClinVar (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/intro/">https://www.ncbi.nlm.nih.gov/clinvar/intro/</ext-link>). Additionally, variants associated with MPS VI can be submitted to the locus‐specific database (<ext-link ext-link-type="uri" xlink:href="http://mps6-database.org">http://mps6-database.org</ext-link>) by email to Hitoshi Sakuraba (<email>sakuraba@my-pharm.ac.jp</email>). These considerations are especially important in MPS VI due to the severity of the disease, broad clinical spectrum, and high level of genetic diversity displayed in individuals with MPS VI, as well as the availability of ERT for these patients.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supporting information</title>
    <supplementary-material content-type="local-data" id="humu23613-supl-0001">
      <caption>
        <p>Supporting information</p>
      </caption>
      <media xlink:href="HUMU-39-1788-s001.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="humu23613-supl-0002">
      <caption>
        <p>Supporting information</p>
      </caption>
      <media xlink:href="HUMU-39-1788-s002.xlsx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="humu23613-supl-0003">
      <caption>
        <p>Supporting information</p>
      </caption>
      <media xlink:href="HUMU-39-1788-s003.xlsx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="humu23613-sec-0160">
    <title>ACKNOWLEDGMENTS</title>
    <p>Medical writing support was provided by Stacie Dilks, PhD, of Health Interactions, Inc. and funded by BioMarin Pharmaceutical Inc. Additional editorial support was provided by Sara Hawley, MS, and Christine Ly, PharmD, of BioMarin Pharmaceutical Inc. The University of Padova (Italy) has provided support to R. Tomanin and A. Zanetti within the Strategic Project “BIOINFOGEN” (Bioinformatics for Personal Genomics).</p>
  </ack>
  <ack id="humu23613-sec-0170">
    <title>DISCLOSURE STATEMENT</title>
    <p>R. Tomanin, L. Karageorgos, A. Zanetti, and J.J. Hopwood have no conflicts of interest to declare. H. Sakuraba reports grants and personal fees from Sumitomo Dainippon, Co., Ltd. outside of the submitted work and grants from Shire Japan, Co. outside of the submitted work. M. AlSayed has received honorarium and travel reimbursement from BioMarin Pharmaceutical Inc., Shire, and Sanofi Genzyme. M. Bailey and N. Miller are employees and stockholders of BioMarin Pharmaceutical Inc.</p>
  </ack>
  <ref-list id="humu23613-bibl-0001">
    <title>REFERENCES</title>
    <ref id="humu23613-bib-0001">
      <mixed-citation publication-type="journal" id="humu23613-cit-0001"><string-name><surname>Acosta</surname>, <given-names>A. X.</given-names></string-name>, <string-name><surname>Abe‐Sandes</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Giugliani</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name><surname>Bittles</surname>, <given-names>A. H.</given-names></string-name> (<year>2013</year>). <article-title>Delivering genetic education and genetic counseling for rare diseases in rural Brazil</article-title>. <source xml:lang="en">Journal of Genetic Counseling</source>, <volume>22</volume>(<issue>6</issue>), <fpage>830</fpage>–<lpage>834</lpage>.<pub-id pub-id-type="pmid">23338802</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0004">
      <mixed-citation publication-type="journal" id="humu23613-cit-0004"><string-name><surname>Baehner</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Schmiedeskamp</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Krummenauer</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Miebach</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Bajbouj</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Whybra</surname>, <given-names>C.</given-names></string-name>, … <string-name><surname>Beck</surname>, <given-names>M.</given-names></string-name> (<year>2005</year>). <article-title>Cumulative incidence rates of the mucopolysaccharidoses in Germany</article-title>. <source xml:lang="en">Journal of Inherited Metabolic Disease</source>, <volume>28</volume>(<issue>6</issue>), <fpage>1011</fpage>–<lpage>1017</lpage>.<pub-id pub-id-type="pmid">16435194</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0005">
      <mixed-citation publication-type="journal" id="humu23613-cit-0005"><string-name><surname>Biffi</surname>, <given-names>A.</given-names></string-name> (<year>2017</year>). <article-title>Hematopoietic stem cell gene therapy for storage disease: Current and new indications</article-title>. <source xml:lang="en">Molecular Therapy</source>, <volume>25</volume>(<issue>5</issue>), <fpage>1155</fpage>–<lpage>1162</lpage>.<pub-id pub-id-type="pmid">28389320</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0006">
      <mixed-citation publication-type="journal" id="humu23613-cit-0006"><string-name><surname>Bond</surname>, <given-names>C. S.</given-names></string-name>, <string-name><surname>Clements</surname>, <given-names>P. R.</given-names></string-name>, <string-name><surname>Ashby</surname>, <given-names>S. J.</given-names></string-name>, <string-name><surname>Collyer</surname>, <given-names>C. A.</given-names></string-name>, <string-name><surname>Harrop</surname>, <given-names>S. J.</given-names></string-name>, <string-name><surname>Hopwood</surname>, <given-names>J. J.</given-names></string-name>, &amp; <string-name><surname>Guss</surname>, <given-names>J. M.</given-names></string-name> (<year>1997</year>). <article-title>Structure of a human lysosomal sulfatase</article-title>. <source xml:lang="en">Structure</source>, <volume>5</volume>(<issue>2</issue>), <fpage>277</fpage>–<lpage>389</lpage>.<pub-id pub-id-type="pmid">9032078</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0007">
      <mixed-citation publication-type="journal" id="humu23613-cit-0007"><string-name><surname>Bradford</surname>, <given-names>T. M.</given-names></string-name>, <string-name><surname>Litjens</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Parkinson</surname>, <given-names>E. J.</given-names></string-name>, <string-name><surname>Hopwood</surname>, <given-names>J. J.</given-names></string-name>, &amp; <string-name><surname>Brooks</surname>, <given-names>D. A.</given-names></string-name> (<year>2002</year>). <article-title>Mucopolysaccharidosis type VI (Maroteaux–Lamy syndrome): A Y210C mutation causes either altered protein handling or altered protein function of N‐acetylgalatosamine 4‐sulfatase at multiple points in the vacuolar network</article-title>. <source xml:lang="en">Biochemistry</source>, <volume>41</volume>(<issue>15</issue>), <fpage>4962</fpage>–<lpage>4971</lpage>.<pub-id pub-id-type="pmid">11939792</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0008">
      <mixed-citation publication-type="journal" id="humu23613-cit-0008"><string-name><surname>Brands</surname>, <given-names>M. M.</given-names></string-name>, <string-name><surname>Hoogeveen‐Westerveld</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kroos</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Nobel</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Ruijter</surname>, <given-names>G. J.</given-names></string-name>, <string-name><surname>Özkan</surname>, <given-names>L.</given-names></string-name>, … <string-name><surname>Reuser</surname>, <given-names>A. J.</given-names></string-name> (<year>2013a</year>). <article-title>Mucopolysaccharidosis type VI phenotypes‐genotypes and antibody response to galsulfase</article-title>. <source xml:lang="en">Orphanet Journal of Rare Diseases</source>, <volume>8</volume>(<issue>1</issue>), <fpage>51</fpage>.<pub-id pub-id-type="pmid">23557332</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0010">
      <mixed-citation publication-type="journal" id="humu23613-cit-0010"><string-name><surname>Brooks</surname>, <given-names>D. A.</given-names></string-name>, <string-name><surname>Robertson</surname>, <given-names>D. A.</given-names></string-name>, <string-name><surname>Bindloss</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Litjens</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Anson</surname>, <given-names>D. S.</given-names></string-name>, <string-name><surname>Peters</surname>, <given-names>C.</given-names></string-name>, … <string-name><surname>Hopwood</surname>, <given-names>J. J.</given-names></string-name> (<year>1995</year>). <article-title>Two site‐directed mutations abrogate enzyme activity but have different effects on the conformation and cellular content of the N‐acetylgalactosamine‐ 4‐sulphatase protein</article-title>. <source xml:lang="en">Biochemical Journal</source>, <volume>307</volume>, <fpage>457</fpage>–<lpage>463</lpage>.<pub-id pub-id-type="pmid">7733883</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0013">
      <mixed-citation publication-type="journal" id="humu23613-cit-0013"><string-name><surname>Chistiakov</surname>, <given-names>D. A.</given-names></string-name>, <string-name><surname>Savost'anov</surname>, <given-names>K. V.</given-names></string-name>, <string-name><surname>Kuzenkova</surname>, <given-names>L. M.</given-names></string-name>, <string-name><surname>Gevorkyan</surname>, <given-names>A. K.</given-names></string-name>, <string-name><surname>Pushkov</surname>, <given-names>A. A.</given-names></string-name>, <string-name><surname>Nikitin</surname>, <given-names>A. G.</given-names></string-name>, … <string-name><surname>Baranov</surname>, <given-names>A. A.</given-names></string-name> (<year>2014</year>). <article-title>Molecular characteristics of patients with glycosaminoglycan storage disorders in Russia</article-title>. <source xml:lang="en">Clinica Chimica Acta</source>, <volume>436</volume>, <fpage>112</fpage>–<lpage>120</lpage>.</mixed-citation>
    </ref>
    <ref id="humu23613-bib-0014">
      <mixed-citation publication-type="journal" id="humu23613-cit-0014"><string-name><surname>Cobos</surname>, <given-names>P. N.</given-names></string-name>, <string-name><surname>Steglich</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Santer</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Lukacs</surname>, <given-names>Z.</given-names></string-name>, &amp; <string-name><surname>Gal</surname>, <given-names>A.</given-names></string-name> (<year>2015</year>). <article-title>Dried blood spots allow targeted screening to diagnose mucopolysaccharidosis and mucolipidosis</article-title>. <source xml:lang="en">JIMD Reports</source>, <volume>15</volume>, <fpage>123</fpage>–<lpage>132</lpage>.<pub-id pub-id-type="pmid">24798265</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0015">
      <mixed-citation publication-type="journal" id="humu23613-cit-0015"><string-name><surname>Colón</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Alvarez</surname>, <given-names>J. V.</given-names></string-name>, <string-name><surname>Castaño</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Gutierrez‐Solana</surname>, <given-names>L. G.</given-names></string-name>, <string-name><surname>Marquez</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>O'Callaghan</surname>, <given-names>M.</given-names></string-name>, … <string-name><surname>Couce</surname>, <given-names>M. L.</given-names></string-name> (<year>2017</year>). <article-title>A selective screening program for the early detection of mucopolysaccharidosis: Results of the FIND project – a 2‐year follow‐up study</article-title>. <source xml:lang="en">Medicine</source>, <volume>96</volume>(<issue>19</issue>), <fpage>e6887</fpage>.<pub-id pub-id-type="pmid">28489793</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0016">
      <mixed-citation publication-type="journal" id="humu23613-cit-0016"><string-name><surname>Costa‐Motta</surname>, <given-names>F. M.</given-names></string-name>, <string-name><surname>Acosta</surname>, <given-names>A. X.</given-names></string-name>, <string-name><surname>Abé‐Sandes</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Bender</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Schwartz</surname>, <given-names>I. V.</given-names></string-name>, <string-name><surname>Giugliani</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name><surname>Leistner‐Segal</surname>, <given-names>S.</given-names></string-name> (<year>2011</year>). <article-title>Genetic studies in a cluster of mucopolysaccharidosis type VI patients in Northeast Brazil</article-title>. <source xml:lang="en">Molecular Genetics and Metabolism</source>, <volume>104</volume>(<issue>4</issue>), <fpage>603</fpage>–<lpage>607</lpage>.<pub-id pub-id-type="pmid">21996138</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0017">
      <mixed-citation publication-type="journal" id="humu23613-cit-0017"><string-name><surname>Costa‐Motta</surname>, <given-names>F. M.</given-names></string-name>, <string-name><surname>Bender</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Acosta</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Abé‐Sandes</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Machado</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Bomfim</surname>, <given-names>T.</given-names></string-name>, … <string-name><surname>Leistner‐Segal</surname>, <given-names>S.</given-names></string-name> (<year>2014</year>). <article-title>A community‐based study of mucopolysaccharidosis type VI in Brazil: The influence of founder effect, endogamy, and consanguinity</article-title>. <source xml:lang="en">Human Heredity</source>, <volume>77</volume>(<issue>1–4</issue>), <fpage>189</fpage>–<lpage>196</lpage>.<pub-id pub-id-type="pmid">25060283</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0019">
      <mixed-citation publication-type="journal" id="humu23613-cit-0019"><string-name><surname>Di Natale</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Villani</surname>, <given-names>G. R. D.</given-names></string-name>, <string-name><surname>Parini</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Scarpa</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Parenti</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Pontarelli</surname>, <given-names>G.</given-names></string-name>, … <string-name><surname>Fiumara</surname>, <given-names>A.</given-names></string-name> (<year>2008</year>). <article-title>Molecular markers for the follow‐up of enzyme‐replacement therapy in mucopolysaccharidosis type VI disease</article-title>. <source xml:lang="en">Biotechnology and Applied Biochemistry</source>, <volume>49</volume>, <fpage>219</fpage>–<lpage>223</lpage>.<pub-id pub-id-type="pmid">17672828</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0022">
      <mixed-citation publication-type="journal" id="humu23613-cit-0022"><string-name><surname>Ferla</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Claudiani</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Savarese</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kozarsky</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Parini</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Scarpa</surname>, <given-names>M.</given-names></string-name>, … <string-name><surname>Auricchio</surname>, <given-names>A.</given-names></string-name> (<year>2015</year>). <article-title>Prevalence of anti‐adeno‐associated virus serotype 8 neutralizing antibodies and arylsulfatase B cross‐reactive immunologic material in mucopolysaccharidosis VI patient candidates for a gene therapy trial</article-title>. <source xml:lang="en">Human Gene Therapy</source>, <volume>26</volume>(<issue>3</issue>), <fpage>145</fpage>–<lpage>152</lpage>.<pub-id pub-id-type="pmid">25654180</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0023">
      <mixed-citation publication-type="journal" id="humu23613-cit-0023"><string-name><surname>Fernández‐Marmiesse</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Morey</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Pineda</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Eiris</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Couce</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Castro‐Gago</surname>, <given-names>M.</given-names></string-name>, … <string-name><surname>Cocho</surname>, <given-names>J. A.</given-names></string-name> (<year>2014</year>). <article-title>Assessment of a targeted resequencing support tool in the diagnosis of lysosomal storage disorders</article-title>. <source xml:lang="en">Orphanet Journal of Rare Diseases</source>, <volume>9</volume>(<issue>1</issue>), <fpage>59</fpage>.<pub-id pub-id-type="pmid">24767253</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0025">
      <mixed-citation publication-type="journal" id="humu23613-cit-0025"><string-name><surname>Furujo</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kubo</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kosuga</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Okuyama</surname>, <given-names>T.</given-names></string-name> (<year>2011</year>). <article-title>Enzyme replacement therapy attenuates disease progression in two Japanese siblings with mucopolysaccharidosis type VI</article-title>. <source xml:lang="en">Molecular Genetics and Metabolism</source>, <volume>104</volume>(<issue>4</issue>), <fpage>597</fpage>–<lpage>602</lpage>.<pub-id pub-id-type="pmid">21930407</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0026">
      <mixed-citation publication-type="journal" id="humu23613-cit-0026"><string-name><surname>Garcia</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Sousa</surname>, <given-names>S. B.</given-names></string-name>, <string-name><surname>Ling</surname>, <given-names>T. P.</given-names></string-name>, <string-name><surname>Conceição</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Seabra</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>White</surname>, <given-names>K. K.</given-names></string-name>, &amp; <string-name><surname>Diogo</surname>, <given-names>L.</given-names></string-name> (<year>2010</year>). <article-title>Skeletal complications in mucopolysaccharidosis VI patients: Case reports</article-title>. <source xml:lang="en">Journal of Pediatric Rehabilitation Medicine</source>, <volume>3</volume>(<issue>1</issue>), <fpage>63</fpage>–<lpage>69</lpage>.<pub-id pub-id-type="pmid">21791831</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0027">
      <mixed-citation publication-type="journal" id="humu23613-cit-0027"><string-name><surname>Garrido</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Chabás</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Coll</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Blanco</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Domínguez</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Grinberg</surname>, <given-names>D.</given-names></string-name>, … <string-name><surname>Cormand</surname>, <given-names>B.</given-names></string-name> (<year>2007</year>). <article-title>Identification of molecular defects in Spanish and Argentinian mucopolysaccharidosis VI (Maroteaux–Lamy syndrome) patients, including 9 novel mutations</article-title>. <source xml:lang="en">Molecular Genetics and Metabolism</source>, <volume>92</volume>(<issue>1‐2</issue>), <fpage>122</fpage>–<lpage>130</lpage>.<pub-id pub-id-type="pmid">17643332</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0029">
      <mixed-citation publication-type="journal" id="humu23613-cit-0029"><string-name><surname>Golda</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Jurecka</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name><surname>Tylki‐Szymanska</surname>, <given-names>A.</given-names></string-name> (<year>2012</year>). <article-title>Cardiovascular manifestations of mucopolysaccharidosis type VI (Maroteaux–Lamy syndrome)</article-title>. <source xml:lang="en">International Journal of Cardiology</source>, <volume>158</volume>(<issue>1</issue>), <fpage>6</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="pmid">21737154</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0030">
      <mixed-citation publication-type="journal" id="humu23613-cit-0030"><string-name><surname>Gottwald</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Hughes</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Stewart</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Tylee</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Church</surname>, <given-names>H.</given-names></string-name>, &amp; <string-name><surname>Jones</surname>, <given-names>S. A.</given-names></string-name> (<year>2011</year>). <article-title>Attenuated mucopolysaccharidosis type VI (Maroteau‐Lamy syndrome) due to homozygosity for the p.Tyr201Cys mutation in the ARSB gene</article-title>. <source xml:lang="en">Molecular Genetics and Metabolism</source>, <volume>103</volume>(<issue>3</issue>), <fpage>300</fpage>–<lpage>302</lpage>.<pub-id pub-id-type="pmid">21514195</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0031">
      <mixed-citation publication-type="journal" id="humu23613-cit-0031"><string-name><surname>Giugliani</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Lampe</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Guffon</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Ketteridge</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Leão‐Teles</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Wraith</surname>, <given-names>J. E.</given-names></string-name>, … <string-name><surname>Harmatz</surname>, <given-names>P.</given-names></string-name> (<year>2014</year>). <article-title>Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux–Lamy syndrome) – 10‐year follow‐up of patients who previously participated in an MPS VI Survey Study</article-title>. <source xml:lang="en">American Journal of Medical Genetics Part A</source>, <volume>164A</volume>(<issue>8</issue>), <fpage>1953</fpage>–<lpage>1964</lpage>.<pub-id pub-id-type="pmid">24764221</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0032">
      <mixed-citation publication-type="journal" id="humu23613-cit-0032"><string-name><surname>Harmatz</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Giugliani</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Schwartz</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Guffon</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Teles</surname>, <given-names>E. L.</given-names></string-name>, <string-name><surname>Miranda</surname>, <given-names>M. C.</given-names></string-name>, … <string-name><surname>Swiedler</surname>, <given-names>S. J.</given-names></string-name> (<year>2006</year>). <article-title>Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double‐blind, placebo‐controlled, multinational study of recombinant human N‐acetylgalactosamine 4‐sulfatase (recombinant human arylsulfatase B or rhASB) and follow‐on, open‐label extension study</article-title>. <source xml:lang="en">Journal of Pediatrics</source>, <volume>148</volume>(<issue>4</issue>), <fpage>533</fpage>–<lpage>539</lpage>.<pub-id pub-id-type="pmid">16647419</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0033">
      <mixed-citation publication-type="journal" id="humu23613-cit-0033"><string-name><surname>Harmatz</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Giugliani</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Schwartz</surname>, <given-names>I. V.</given-names></string-name>, <string-name><surname>Guffon</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Teles</surname>, <given-names>E. L.</given-names></string-name>, <string-name><surname>Miranda</surname>, <given-names>M. C.</given-names></string-name>, …<string-name><surname>Decker</surname>, <given-names>C.</given-names></string-name> (<year>2008</year>). <article-title>Long‐term follow‐up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N‐acetylgalactosamine 4‐sulfatase</article-title>. <source xml:lang="en">Molecular Genetics and Metabolism</source>, <volume>94</volume>(<issue>4</issue>), <fpage>469</fpage>–<lpage>475</lpage>.<pub-id pub-id-type="pmid">18502162</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0034">
      <mixed-citation publication-type="journal" id="humu23613-cit-0034"><string-name><surname>Harmatz</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Yu</surname>, <given-names>Z. F.</given-names></string-name>, <string-name><surname>Giugliani</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Schwartz</surname>, <given-names>I. V. D.</given-names></string-name>, <string-name><surname>Guffon</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Teles</surname>, <given-names>E. L.</given-names></string-name>, … <string-name><surname>Decker</surname>, <given-names>C.</given-names></string-name> (<year>2010</year>). <article-title>Enzyme replacement therapy for mucopolysaccharidosis VI: Evaluation of long‐term pulmonary function in patients treated with recombinant human N‐acetylgalactosamine 4‐sulfatase</article-title>. <source xml:lang="en">Journal of Inherited Metabolic Disease</source>, <volume>33</volume>(<issue>1</issue>), <fpage>51</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="pmid">20140523</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0035">
      <mixed-citation publication-type="journal" id="humu23613-cit-0035"><string-name><surname>Harmatz</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Garcia</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Guffon</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Randolph</surname>, <given-names>L. M.</given-names></string-name>, <string-name><surname>Shediac</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Braunlin</surname>, <given-names>E.</given-names></string-name>, … <string-name><surname>Decker</surname>, <given-names>C.</given-names></string-name> (<year>2014</year>). <article-title>Galsulfase (Naglazyme<sup>®</sup>) therapy in infants with mucopolysaccharidosis VI</article-title>. <source xml:lang="en">Journal of Inherited Metabolic Disease</source>, <volume>37</volume>(<issue>2</issue>), <fpage>277</fpage>–<lpage>287</lpage>.<pub-id pub-id-type="pmid">24108527</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0036">
      <mixed-citation publication-type="miscellaneous" id="humu23613-cit-0036"><string-name><surname>Hart</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Blyth</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Chiu</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Fusaro</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Garcia</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Hare</surname>, <given-names>E.</given-names></string-name>, … <string-name><surname>Westbrook</surname>, <given-names>J.</given-names></string-name> (<year>2014</year>). <article-title>CLINVITAE: An open database of clinically observed variants, and other open source tools from Invitae. Poster Presented at Pacific Symposium on Biocomputing. Hawaii, USA</article-title>.</mixed-citation>
    </ref>
    <ref id="humu23613-bib-0037">
      <mixed-citation publication-type="journal" id="humu23613-cit-0037"><string-name><surname>Hopkins</surname>, <given-names>P. V.</given-names></string-name>, <string-name><surname>Campbell</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Klug</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Rogers</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Raburn‐Miller</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name><surname>Kiesling</surname>, <given-names>J.</given-names></string-name> (<year>2015</year>). <article-title>Lysosomal storage disorder screening implementation: Findings from the first six months of full population pilot testing in Missouri</article-title>. <source xml:lang="en">Journal of Pediatrics</source>, <volume>166</volume>(<issue>1</issue>), <fpage>172</fpage>–<lpage>177</lpage>.<pub-id pub-id-type="pmid">25444528</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0039">
      <mixed-citation publication-type="journal" id="humu23613-cit-0039"><string-name><surname>Hunt</surname>, <given-names>R. C.</given-names></string-name>, <string-name><surname>Simhadri</surname>, <given-names>V. L.</given-names></string-name>, <string-name><surname>Iandoli</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Sauna</surname>, <given-names>Z. E.</given-names></string-name>, &amp; <string-name><surname>Kimchi‐Sarfaty</surname>, <given-names>C.</given-names></string-name> (<year>2014</year>). <article-title>Exposing synonymous mutations</article-title>. <source xml:lang="en">Trends in Genetics</source>, <volume>30</volume>(<issue>7</issue>), <fpage>308</fpage>–<lpage>321</lpage>.<pub-id pub-id-type="pmid">24954581</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0040">
      <mixed-citation publication-type="journal" id="humu23613-cit-0040"><string-name><surname>Isbrandt</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Arlt</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Brooks</surname>, <given-names>D. A.</given-names></string-name>, <string-name><surname>Hopwood</surname>, <given-names>J. J.</given-names></string-name>, <string-name><surname>von Figura</surname>, <given-names>K.</given-names></string-name>, &amp; <string-name><surname>Peters</surname>, <given-names>C.</given-names></string-name> (<year>1994</year>). <article-title>Mucopolysaccharidosis VI (Maroteaux–Lamy syndrome): Six unique arylsulfatase B gene alleles causing variable disease phenotypes</article-title>. <source xml:lang="en">American Journal of Human Genetics</source>, <volume>54</volume>(<issue>3</issue>), <fpage>454</fpage>–<lpage>463</lpage>.<pub-id pub-id-type="pmid">8116615</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0042">
      <mixed-citation publication-type="journal" id="humu23613-cit-0042"><string-name><surname>Ittiwut</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Boonbuamas</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Srichomthong</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Ittiwut</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Suphapeetiporn</surname>, <given-names>K.</given-names></string-name>, &amp; <string-name><surname>Shotelersuk</surname>, <given-names>V.</given-names></string-name> (<year>2017</year>). <article-title>Novel mutations, including a large deletion in the ARSB gene, causing mucopolysaccharidosis type VI</article-title>. <source xml:lang="en">Genetic Testing and Molecular Biomarkers</source>, <volume>21</volume>(<issue>1</issue>), <fpage>58</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">27797586</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0045">
      <mixed-citation publication-type="journal" id="humu23613-cit-0045"><string-name><surname>Jurecka</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Golda</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Opoka‐Winiarska</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Piotrowska</surname>, <given-names>E.</given-names></string-name>, &amp; <string-name><surname>Tylki‐Szymańska</surname>, <given-names>A.</given-names></string-name> (<year>2011a</year>). <article-title>Mucopolysaccharidosis type VI (Maroteaux–Lamy syndrome) with a predominantly cardiac phenotype</article-title>. <source xml:lang="en">Molecular Genetics and Metabolism</source>, <volume>104</volume>(<issue>4</issue>), <fpage>695</fpage>–<lpage>699</lpage>.<pub-id pub-id-type="pmid">21917494</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0046">
      <mixed-citation publication-type="journal" id="humu23613-cit-0046"><string-name><surname>Jurecka</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Rozdzynska</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Marucha</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Czartoryska</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Wegrzyn</surname>, <given-names>G.</given-names></string-name>, &amp; <string-name><surname>Tylki‐Szymanska</surname>, <given-names>A.</given-names></string-name> (<year>2011b</year>). <article-title>Natural history of Polish patients with mucopolysaccharidosis type VI</article-title>. <source xml:lang="en">Central European Journal of Medicine</source>, <volume>6</volume>(<issue>2</issue>), <fpage>163</fpage>–<lpage>171</lpage>.</mixed-citation>
    </ref>
    <ref id="humu23613-bib-0047">
      <mixed-citation publication-type="journal" id="humu23613-cit-0047"><string-name><surname>Jurecka</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Piotrowska</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Cimbalistiene</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Gusina</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Sobczyńska</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Czartoryska</surname>, <given-names>B.</given-names></string-name>, … <string-name><surname>Tylki‐Szymańska</surname>, <given-names>A.</given-names></string-name> (<year>2012a</year>). <article-title>Molecular analysis of mucopolysaccharidosis type VI in Poland, Belarus, Lithuania and Estonia</article-title>. <source xml:lang="en">Molecular Genetics and Metabolism</source>, <volume>105</volume>(<issue>2</issue>), <fpage>237</fpage>–<lpage>243</lpage>.<pub-id pub-id-type="pmid">22133300</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0051">
      <mixed-citation publication-type="journal" id="humu23613-cit-0051"><string-name><surname>Jurecka</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Zakharova</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Cimbalistiene</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Gusina</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Malinova</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Różdżyńska‐Świątkowska</surname>, <given-names>A.</given-names></string-name>, … <string-name><surname>Tylki‐Szymańska</surname>, <given-names>A.</given-names></string-name> (<year>2014b</year>). <article-title>Mucopolysaccharidosis type VI in Russia, Kazakhstan, and Central and Eastern Europe</article-title>. <source xml:lang="en">Pediatrics International</source>, <volume>56</volume>(<issue>4</issue>), <fpage>520</fpage>–<lpage>525</lpage>.<pub-id pub-id-type="pmid">24373060</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0052">
      <mixed-citation publication-type="journal" id="humu23613-cit-0052"><string-name><surname>Jurecka</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ługowska</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Golda</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Czartoryska</surname>, <given-names>B.</given-names></string-name>, &amp; <string-name><surname>Tylki‐Szymańska</surname>, <given-names>A.</given-names></string-name> (<year>2015</year>). <article-title>Prevalence rates of mucopolysaccharidoses in Poland</article-title>. <source xml:lang="en">Journal of Applied Genetics</source>, <volume>56</volume>(<issue>2</issue>), <fpage>205</fpage>–<lpage>210</lpage>.<pub-id pub-id-type="pmid">25472774</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0054">
      <mixed-citation publication-type="journal" id="humu23613-cit-0054"><string-name><surname>Kantaputra</surname>, <given-names>P. K.</given-names></string-name>, <string-name><surname>Kayserili</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Guven</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Kantaputra</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Balci</surname>, <given-names>M. C.</given-names></string-name>, <string-name><surname>Tanpaiboon</surname>, <given-names>P.</given-names></string-name>, … <string-name><surname>Dalal</surname>, <given-names>A.</given-names></string-name> (<year>2014</year>). <article-title>Clinical manifestations of 17 patients affected with mucopolysaccharidosis type VI and eight novel ARSB mutations</article-title>. <source xml:lang="en">American Journal of Medical Genetics Part A</source>, <volume>164A</volume>(<issue>6</issue>), <fpage>1443</fpage>–<lpage>1453</lpage>.<pub-id pub-id-type="pmid">24677745</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0055">
      <mixed-citation publication-type="journal" id="humu23613-cit-0055"><string-name><surname>Karageorgos</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Harmatz</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Simon</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Pollard</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Clements</surname>, <given-names>P. R.</given-names></string-name>, <string-name><surname>Brooks</surname>, <given-names>D. A.</given-names></string-name>, &amp; <string-name><surname>Hopwood</surname>, <given-names>J. J.</given-names></string-name> (<year>2004</year>). <article-title>Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapy</article-title>. <source xml:lang="en">Human Mutation</source>, <volume>23</volume>(<issue>3</issue>), <fpage>229</fpage>–<lpage>233</lpage>.<pub-id pub-id-type="pmid">14974081</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0056">
      <mixed-citation publication-type="journal" id="humu23613-cit-0056"><string-name><surname>Karageorgos</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Brooks</surname>, <given-names>D. A.</given-names></string-name>, <string-name><surname>Harmatz</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Ketteridge</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Pollard</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Melville</surname>, <given-names>E. L.</given-names></string-name>, … <string-name><surname>Hopwood</surname>, <given-names>J. J.</given-names></string-name> (<year>2007a</year>). <article-title>Mutational analysis of mucopolysaccharidosis type VI patients undergoing a phase II trial of enzyme replacement therapy</article-title>. <source xml:lang="en">Molecular Genetics and Metabolism</source>, <volume>90</volume>(<issue>2</issue>), <fpage>164</fpage>–<lpage>170</lpage>.<pub-id pub-id-type="pmid">17161971</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0057">
      <mixed-citation publication-type="journal" id="humu23613-cit-0057"><string-name><surname>Karageorgos</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Brooks</surname>, <given-names>D. A.</given-names></string-name>, <string-name><surname>Pollard</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Melville</surname>, <given-names>E. L.</given-names></string-name>, <string-name><surname>Hein</surname>, <given-names>L. K.</given-names></string-name>, <string-name><surname>Clements</surname>, <given-names>P. R.</given-names></string-name>, … <string-name><surname>Hopwood</surname>, <given-names>J. J.</given-names></string-name> (<year>2007b</year>). <article-title>Mutational analysis of 105 mucopolysaccharidosis type VI patients</article-title>. <source xml:lang="en">Human Mutation</source>, <volume>28</volume>(<issue>9</issue>), <fpage>897</fpage>–<lpage>903</lpage>.<pub-id pub-id-type="pmid">17458871</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0059">
      <mixed-citation publication-type="journal" id="humu23613-cit-0059"><string-name><surname>Koc</surname>, <given-names>I.</given-names></string-name> (<year>2008</year>). <article-title>Prevalence and sociodemographic correlates of consanguineous marriages in Turkey</article-title>. <source xml:lang="en">Journal of Biosocial Science</source>, <volume>40</volume>(<issue>1</issue>), <fpage>137</fpage>–<lpage>148</lpage>.<pub-id pub-id-type="pmid">18028574</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0062">
      <mixed-citation publication-type="journal" id="humu23613-cit-0062"><string-name><surname>Lin</surname>, <given-names>S. P.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>H. Y.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>T. J.</given-names></string-name>, <string-name><surname>Chang</surname>, <given-names>C. Y.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>C. H.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>S. F.</given-names></string-name>, … <string-name><surname>Chuang</surname>, <given-names>C. K.</given-names></string-name> (<year>2013</year>). <article-title>A pilot newborn screening program for mucopolysacchardiosis type I in Taiwan</article-title>. <source xml:lang="en">Orphanet Journal of Rare Diseases</source>, <volume>8</volume>(<issue>1</issue>), <fpage>147</fpage>.<pub-id pub-id-type="pmid">24053568</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0063">
      <mixed-citation publication-type="journal" id="humu23613-cit-0063"><string-name><surname>Lin</surname>, <given-names>W. D.</given-names></string-name>, <string-name><surname>Ke</surname>, <given-names>Y. Y.</given-names></string-name>, <string-name><surname>Chou</surname>, <given-names>I. C.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>C. H.</given-names></string-name>, &amp; <string-name><surname>Tsai</surname>, <given-names>F. J.</given-names></string-name> (<year>2015</year>). <article-title>Deletion of exon 4 in the N‐acetylgalactosamine‐4‐sulfatase gene in a Taiwanese patient with mucopolysaccharidosis type VI</article-title>. <source xml:lang="en">Tohoku Journal of Experimental Medicine</source>, <volume>235</volume>(<issue>4</issue>), <fpage>267</fpage>–<lpage>273</lpage>.<pub-id pub-id-type="pmid">25797215</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0064">
      <mixed-citation publication-type="journal" id="humu23613-cit-0064"><string-name><surname>Lin</surname>, <given-names>W. E.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>S. P.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>C. H.</given-names></string-name>, <string-name><surname>Hwu</surname>, <given-names>W. L.</given-names></string-name>, <string-name><surname>Chuang</surname>, <given-names>C. K.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>S. J.</given-names></string-name>, … <string-name><surname>Tsai</surname>, <given-names>F. J.</given-names></string-name> (<year>2008</year>). <article-title>Genetic analysis of mucopolysaccharidosis type VI in Taiwanese patients</article-title>. <source xml:lang="en">Clinica Chimica Acta</source>, <volume>394</volume>(<issue>1–2</issue>), <fpage>89</fpage>–<lpage>93</lpage>.</mixed-citation>
    </ref>
    <ref id="humu23613-bib-0065">
      <mixed-citation publication-type="journal" id="humu23613-cit-0065"><string-name><surname>Litjens</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Baker</surname>, <given-names>E. G.</given-names></string-name>, <string-name><surname>Beckmann</surname>, <given-names>K. R.</given-names></string-name>, <string-name><surname>Morris</surname>, <given-names>C. P.</given-names></string-name>, <string-name><surname>Hopwood</surname>, <given-names>J. J.</given-names></string-name>, &amp; <string-name><surname>Callen</surname>, <given-names>D. F.</given-names></string-name> (<year>1989</year>). <article-title>Chromosomal localization of ARSB, the gene for human N‐acetylfalactosamine‐4‐sulfatase</article-title>. <source xml:lang="en">Human Genetics</source>, <volume>82</volume>(<issue>1</issue>), <fpage>67</fpage>–<lpage>68</lpage>.<pub-id pub-id-type="pmid">2714781</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0067">
      <mixed-citation publication-type="journal" id="humu23613-cit-0067"><string-name><surname>Litjens</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Brooks</surname>, <given-names>D. A.</given-names></string-name>, <string-name><surname>Peters</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Gibson</surname>, <given-names>G. J.</given-names></string-name>, &amp; <string-name><surname>Hopwood</surname>, <given-names>J. J.</given-names></string-name> (<year>1996</year>). <article-title>Identification, expression, and biochemical characterization of N‐acetylgalactosamine‐4‐sulfatase mutations and relationship with clinical phenotype in MPS‐VI patients</article-title>. <source xml:lang="en">American Journal of Human Genetics</source>, <volume>58</volume>(<issue>6</issue>), <fpage>1127</fpage>–<lpage>1134</lpage>.<pub-id pub-id-type="pmid">8651289</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0068">
      <mixed-citation publication-type="journal" id="humu23613-cit-0068"><string-name><surname>Litjens</surname>, <given-names>T.</given-names></string-name>, &amp; <string-name><surname>Hopwood</surname>, <given-names>J. J.</given-names></string-name> (<year>2001</year>). <article-title>Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N‐acetylgalactosamine‐4‐sulfatase</article-title>. <source xml:lang="en">Human Mutation</source>, <volume>18</volume>(<issue>4</issue>), <fpage>282</fpage>–<lpage>295</lpage>.<pub-id pub-id-type="pmid">11668612</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0069">
      <mixed-citation publication-type="journal" id="humu23613-cit-0069"><string-name><surname>Lohmann</surname>, <given-names>K.</given-names></string-name>, &amp; <string-name><surname>Klein</surname>, <given-names>C.</given-names></string-name> (<year>2014</year>). <article-title>Next generation sequencing and the future of genetic diagnosis</article-title>. <source xml:lang="en">Neurotherapeutics</source>, <volume>11</volume>(<issue>4</issue>), <fpage>699</fpage>–<lpage>707</lpage>.<pub-id pub-id-type="pmid">25052068</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0070">
      <mixed-citation publication-type="journal" id="humu23613-cit-0070"><string-name><surname>Macauley</surname>, <given-names>S. L.</given-names></string-name> (<year>2016</year>). <article-title>Combination therapies for lysosomal storage diseases: A complex answer to a simple problem</article-title>. <source xml:lang="en">Pediatric Endocrinology Reviews</source>, <volume>13</volume>(<issue>1</issue>), <fpage>639</fpage>–<lpage>648</lpage>.<pub-id pub-id-type="pmid">27491211</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0071">
      <mixed-citation publication-type="journal" id="humu23613-cit-0071"><string-name><surname>Mathew</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Jagadeesh</surname>, <given-names>S. M.</given-names></string-name>, <string-name><surname>Bhat</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kumar</surname>, <given-names>S. U.</given-names></string-name>, <string-name><surname>Thiyagarjan</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Srinivasan</surname>, <given-names>S.</given-names></string-name> (<year>2015</year>). <article-title>Mutations in ARSB in MPS VI patients in India</article-title>. <source xml:lang="en">Molecular Genetics and Metabolism Reports</source>, <volume>4</volume>, <fpage>53</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="pmid">26937411</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0072">
      <mixed-citation publication-type="journal" id="humu23613-cit-0072"><string-name><surname>McGill</surname>, <given-names>J. J.</given-names></string-name>, <string-name><surname>Inwood</surname>, <given-names>A. C.</given-names></string-name>, <string-name><surname>Coman</surname>, <given-names>D. J.</given-names></string-name>, <string-name><surname>Lipkie</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>de Lore</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Sweidler</surname>, <given-names>S. J.</given-names></string-name>, &amp; <string-name><surname>Hopwood</surname>, <given-names>J. J.</given-names></string-name> (<year>2010</year>). <article-title>Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age—A sibling control study</article-title>. <source xml:lang="en">Clinical Genetics</source>, <volume>77</volume>(<issue>5</issue>), <fpage>492</fpage>–<lpage>498</lpage>.<pub-id pub-id-type="pmid">19968667</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0073">
      <mixed-citation publication-type="journal" id="humu23613-cit-0073"><string-name><surname>McGovern</surname>, <given-names>M. M.</given-names></string-name>, <string-name><surname>Vine</surname>, <given-names>D. T.</given-names></string-name>, <string-name><surname>Haskins</surname>, <given-names>M. E.</given-names></string-name>, &amp; <string-name><surname>Desnick</surname>, <given-names>R. J.</given-names></string-name> (<year>1982</year>). <article-title>Purification and properties of feline and human arylsulfatase B isozymes. Evidence for feline homodimeric and human monomeric structures</article-title>. <source xml:lang="en">Journal of Biological Chemistry</source>, <volume>257</volume>(<issue>21</issue>), <fpage>12605</fpage>–<lpage>12610</lpage>.<pub-id pub-id-type="pmid">7130169</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0074">
      <mixed-citation publication-type="journal" id="humu23613-cit-0074"><string-name><surname>Mechtler</surname>, <given-names>T. P.</given-names></string-name>, <string-name><surname>Stary</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Metz</surname>, <given-names>T. F.</given-names></string-name>, <string-name><surname>De Jesus</surname>, <given-names>V. R.</given-names></string-name>, <string-name><surname>Greber‐Platzer</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Pollak</surname>, <given-names>A.</given-names></string-name>, … <string-name><surname>Kasper</surname>, <given-names>D. C.</given-names></string-name> (<year>2012</year>). <article-title>Neonatal screening for lysosomal storage disorders: Feasibility and incidence from a nationwide study in Austria</article-title>. <source xml:lang="en">Lancet</source>, <volume>379</volume>, <fpage>335</fpage>–<lpage>341</lpage>.<pub-id pub-id-type="pmid">22133539</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0075">
      <mixed-citation publication-type="journal" id="humu23613-cit-0075"><string-name><surname>Meikle</surname>, <given-names>P. J.</given-names></string-name>, &amp; <string-name><surname>Hopwood</surname>, <given-names>J. J.</given-names></string-name> (<year>2003</year>). <article-title>Lysosomal storage disorders: Emerging therapeutic options require early diagnosis</article-title>. <source xml:lang="en">European Journal of Pediatrics</source>, <volume>162</volume>, <fpage>S34</fpage>–<lpage>S37</lpage>.<pub-id pub-id-type="pmid">14610674</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0076">
      <mixed-citation publication-type="journal" id="humu23613-cit-0076"><string-name><surname>Mendelsohn</surname>, <given-names>N. J.</given-names></string-name>, <string-name><surname>Wood</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Olson</surname>, <given-names>R. A.</given-names></string-name>, <string-name><surname>Temme</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Hale</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>H.</given-names></string-name>, … <string-name><surname>White</surname>, <given-names>K. K.</given-names></string-name> (<year>2013</year>). <article-title>Spondyloepiphyseal dysplasias and bilateral Legg‐Calvé‐Perthes disease: Diagnostic considerations for mucopolysaccharidoses</article-title>. <source xml:lang="en">JIMD Reports</source>, <volume>11</volume>, <fpage>125</fpage>–<lpage>132</lpage>.<pub-id pub-id-type="pmid">23657977</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0077">
      <mixed-citation publication-type="journal" id="humu23613-cit-0077"><string-name><surname>Moammar</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Cheriyan</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Mathew</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name><surname>Al‐Sannaa</surname>, <given-names>N.</given-names></string-name> (<year>2010</year>). <article-title>Incidence and patterns of inborn errors of metabolism in the Eastern Province of Saudi Arabia, 1983–2008</article-title>. <source xml:lang="en">Annals of Saudi Medicine</source>, <volume>30</volume>(<issue>4</issue>), <fpage>271</fpage>–<lpage>277</lpage>.<pub-id pub-id-type="pmid">20622343</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0078">
      <mixed-citation publication-type="journal" id="humu23613-cit-0078"><string-name><surname>Muenzer</surname>, <given-names>J.</given-names></string-name> (<year>2014</year>). <article-title>Early initiation of enzyme replacement therapy for the mucopolysaccharidoses</article-title>. <source xml:lang="en">Molecular Genetics and Metabolism</source>, <volume>111</volume>(<issue>2</issue>), <fpage>63</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">24388732</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0079">
      <element-citation publication-type="miscellaneous" id="humu23613-cit-0079">
        <article-title>Naglazyme (galsulfase) [package insert]. (2013). Novato, CA: BioMarin Pharmaceutical, Inc.</article-title>
      </element-citation>
    </ref>
    <ref id="humu23613-bib-0080">
      <mixed-citation publication-type="journal" id="humu23613-cit-0080"><string-name><surname>Navarrete‐Martínez</surname>, <given-names>J. I.</given-names></string-name>, <string-name><surname>Limón‐Rojas</surname>, <given-names>A. E.</given-names></string-name>, <string-name><surname>Gaytán‐García</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Reyna‐Fiqueroa</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wakida‐Kusunoki</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Delgado‐Calvillo</surname>, <given-names>M. D. R.</given-names></string-name>, … <string-name><surname>Cervantes‐Barragán</surname>, <given-names>D. E.</given-names></string-name> (<year>2017</year>). <article-title>Newborn screening for six lysosomal storage disorders in a cohort of Mexican patients: Three‐year findings from a screening program in a closed Mexican health system</article-title>. <source xml:lang="en">Molecular Genetics and Metabolism</source>, <volume>121</volume>(<issue>1</issue>), <fpage>16</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">28302345</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0081">
      <mixed-citation publication-type="journal" id="humu23613-cit-0081"><string-name><surname>Nouri</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Nouri</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Aryani</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Kamalidehghan</surname>, <given-names>B.</given-names></string-name>, &amp; <string-name><surname>Houshmand</surname>, <given-names>M.</given-names></string-name> (<year>2012</year>). <article-title>Identification of a novel arylsulfatase B gene mutation in three unrelated Iranian mucopolysaccharidosis type‐VI patients with different phenotype severity</article-title>. <source xml:lang="en">Iranian Biomedical Journal</source>, <volume>16</volume>(<issue>3</issue>), <fpage>1</fpage>–<lpage>3</lpage>.<pub-id pub-id-type="pmid">22562026</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0084">
      <mixed-citation publication-type="journal" id="humu23613-cit-0084"><string-name><surname>Peters</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Schmidt</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Rommerskirch</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Rupp</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Zühlsdorf</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Vingron</surname>, <given-names>M.</given-names></string-name>, … <string-name><surname>von Figura</surname>, <given-names>K.</given-names></string-name> (<year>1990</year>). <article-title>Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human arylsulfatase B</article-title>. <source xml:lang="en">Journal of Biological Chemistry</source>, <volume>265</volume>(<issue>6</issue>), <fpage>3374</fpage>–<lpage>3381</lpage>.<pub-id pub-id-type="pmid">2303452</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0085">
      <mixed-citation publication-type="journal" id="humu23613-cit-0085"><string-name><surname>Petry</surname>, <given-names>M. F. G.</given-names></string-name>, <string-name><surname>Nonemacher</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Sebben</surname>, <given-names>J. C.</given-names></string-name>, <string-name><surname>Schwartz</surname>, <given-names>I. V. D.</given-names></string-name>, <string-name><surname>Azevedo</surname>, <given-names>A. C. M.</given-names></string-name>, <string-name><surname>Burin</surname>, <given-names>M. G.</given-names></string-name>, … <string-name><surname>Leistner‐Segal</surname>, <given-names>S.</given-names></string-name> (<year>2005</year>). <article-title>Mucopolysaccharidosis type VI: Identification of novel mutations on the arylsulfatase B gene in South American patients</article-title>. <source xml:lang="en">Journal of Inherited Metabolic Disease</source>, <volume>28</volume>(<issue>6</issue>), <fpage>1027</fpage>–<lpage>1034</lpage>.<pub-id pub-id-type="pmid">16435196</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0087">
      <mixed-citation publication-type="journal" id="humu23613-cit-0087"><string-name><surname>Quartel</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Harmatz</surname>, <given-names>P. R.</given-names></string-name>, <string-name><surname>Lampe</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Guffon</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Ketteridge</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Leão‐Teles</surname>, <given-names>E.</given-names></string-name>, … <string-name><surname>Giugliani</surname>, <given-names>R.</given-names></string-name> (<year>2018</year>). <article-title>Long‐term galsulfase treatment associated with improved survival of patients with mucopolysaccharidosis VI (Maroteaux–Lamy syndrome): 15‐year follow‐up study from the survey study</article-title>. <source xml:lang="en">Journal of Inborn Errors of Metabolism and Screening</source>, <volume>6</volume>, <fpage>1</fpage>–<lpage>6</lpage>.</mixed-citation>
    </ref>
    <ref id="humu23613-bib-0088">
      <mixed-citation publication-type="journal" id="humu23613-cit-0088"><string-name><surname>Rastall</surname>, <given-names>D. P. W.</given-names></string-name>, &amp; <string-name><surname>Amalfitano</surname>, <given-names>A.</given-names></string-name> (<year>2015</year>). <article-title>Recent advances in gene therapy for lysosomal storage disorders</article-title>. <source xml:lang="en">Application of Clinical Genetics</source>, <volume>8</volume>, <fpage>157</fpage>–<lpage>169</lpage>.<pub-id pub-id-type="pmid">26170711</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0089">
      <mixed-citation publication-type="journal" id="humu23613-cit-0089"><string-name><surname>Richards</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Aziz</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Bale</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Bick</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Das</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Gastier‐Foster</surname>, <given-names>J.</given-names></string-name>, … <string-name><surname>Rehm</surname>, <given-names>H. L.</given-names></string-name> (<year>2015</year>). <article-title>Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>. <source xml:lang="en">Genetics in Medicine</source>, <volume>17</volume>(<issue>5</issue>), <fpage>405</fpage>–<lpage>424</lpage>.<pub-id pub-id-type="pmid">25741868</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0090">
      <mixed-citation publication-type="journal" id="humu23613-cit-0090"><string-name><surname>Saito</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Ohno</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Sugawara</surname>, <given-names>K.</given-names></string-name>, &amp; <string-name><surname>Sakuraba</surname>, <given-names>H.</given-names></string-name> (<year>2008</year>). <article-title>Structural and clinical implications of amino acid substitution in N‐acetylgalactosamine‐4‐sulfatase: Insight into mucopolysaccharidosis type VI</article-title>. <source xml:lang="en">Molecular Genetics and Metabolism</source>, <volume>93</volume>(<issue>4</issue>), <fpage>419</fpage>–<lpage>425</lpage>.<pub-id pub-id-type="pmid">18248830</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0091">
      <mixed-citation publication-type="journal" id="humu23613-cit-0091"><string-name><surname>Sandberg</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Deanching</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Hoganson</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Wenger</surname>, <given-names>D.</given-names></string-name>, &amp; <string-name><surname>Whitley</surname>, <given-names>C.</given-names></string-name> (<year>2008</year>). <article-title>Pseudo‐deficiency allele of the N‐acetylgalactosamine‐4‐sulfatase gene identified in a family with Maroteaux–Lamy syndrome (mucopolysaccharidosis type VI)</article-title>. <source xml:lang="en">Molecular Genetics and Metabolism</source>, <volume>93</volume>(<issue>2</issue>), <fpage>34</fpage>.</mixed-citation>
    </ref>
    <ref id="humu23613-bib-0094">
      <mixed-citation publication-type="journal" id="humu23613-cit-0094"><string-name><surname>Simonaro</surname>, <given-names>C. M.</given-names></string-name>, &amp; <string-name><surname>Schuchman</surname>, <given-names>E. H.</given-names></string-name> (<year>1995</year>). <article-title>N‐acetylgalactosamine‐4‐sulfatase: Identification of four new mutations within the conserved sulfatase region causing mucopolysaccharidosis type VI</article-title>. <source xml:lang="en">Biochimica et Biophysica Acta</source>, <volume>1272</volume>(<issue>3</issue>), <fpage>129</fpage>–<lpage>132</lpage>.<pub-id pub-id-type="pmid">8541342</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0095">
      <mixed-citation publication-type="journal" id="humu23613-cit-0095"><string-name><surname>Stenson</surname>, <given-names>P. D.</given-names></string-name>, <string-name><surname>Ball</surname>, <given-names>E. V.</given-names></string-name>, <string-name><surname>Mort</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Phillips</surname>, <given-names>A. D.</given-names></string-name>, <string-name><surname>Shiel</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Thomas</surname>, <given-names>N. S. T.</given-names></string-name>, …<string-name><surname>Cooper</surname>, <given-names>D. N.</given-names></string-name> (<year>2003</year>). <article-title>Human Gene Mutation Database (HGMD<sup>®</sup>): 2003 update</article-title>. <source xml:lang="en">Human Mutation</source>, <volume>21</volume>(<issue>6</issue>), <fpage>577</fpage>–<lpage>581</lpage>.<pub-id pub-id-type="pmid">12754702</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0096">
      <mixed-citation publication-type="journal" id="humu23613-cit-0096"><string-name><surname>Thümler</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Miebach</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Lampe</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Pitz</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Kamin</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Kampmann</surname>, <given-names>C.</given-names></string-name>, … <string-name><surname>Mengel</surname>, <given-names>E.</given-names></string-name> (<year>2012</year>). <article-title>Clinical characteristics of adults with slowly progressing mucopolysaccharidosis VI: A case series</article-title>. <source xml:lang="en">Journal of Inherited Metabolic Disease</source>, <volume>35</volume>(<issue>6</issue>), <fpage>1071</fpage>–<lpage>1079</lpage>.<pub-id pub-id-type="pmid">22441840</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0097">
      <mixed-citation publication-type="journal" id="humu23613-cit-0097"><string-name><surname>Uttarilli</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ranganath</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Jain</surname>, <given-names>S. J. M. N.</given-names></string-name>, <string-name><surname>Prasad</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Sinha</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Verma</surname>, <given-names>I. C.</given-names></string-name>, … <string-name><surname>Dalal</surname>, <given-names>A. B.</given-names></string-name> (<year>2015</year>). <article-title>Novel mutations of the arylsulfatase B (ARSB) gene in Indian patients with mucopolysaccharidosis type VI</article-title>. <source xml:lang="en">Indian Journal of Medical Research</source>, <volume>142</volume>, <fpage>414</fpage>–<lpage>425</lpage>.<pub-id pub-id-type="pmid">26609033</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0099">
      <mixed-citation publication-type="journal" id="humu23613-cit-0099"><string-name><surname>Vairo</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Federhen</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Baldo</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Riegel</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Burin</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Leistner‐Segal</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Giugliani</surname>, <given-names>R.</given-names></string-name> (<year>2015</year>). <article-title>Diagnostic and treatment strategies in mucopolysaccharidosis VI</article-title>. <source xml:lang="en">Application of Clinical Genetics</source>, <volume>8</volume>, <fpage>245</fpage>–<lpage>255</lpage>.<pub-id pub-id-type="pmid">26586959</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0100">
      <mixed-citation publication-type="journal" id="humu23613-cit-0100"><string-name><surname>Valayannopoulos</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Nicely</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Harmatz</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name><surname>Turbeville</surname>, <given-names>S.</given-names></string-name> (<year>2010</year>). <article-title>Mucopolysaccharidosis VI</article-title>. <source xml:lang="en">Orphanet Journal of Rare Diseases</source>, <volume>5</volume>(<issue>1</issue>), <fpage>5</fpage>.<pub-id pub-id-type="pmid">20385007</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0101">
      <mixed-citation publication-type="journal" id="humu23613-cit-0101"><string-name><surname>Valayannopoulos</surname>, <given-names>V.</given-names></string-name> (<year>2013</year>). <article-title>Enzyme replacement therapy and substrate reduction therapy in lysosomal storage disorders with neurological expression</article-title>. <source xml:lang="en">Handbook of Clinical Neurology</source>, <volume>113</volume>, <fpage>1851</fpage>–<lpage>1857</lpage>.<pub-id pub-id-type="pmid">23622408</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0103">
      <mixed-citation publication-type="journal" id="humu23613-cit-0103"><string-name><surname>Villani</surname>, <given-names>G. R. D.</given-names></string-name>, <string-name><surname>Balzano</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Vitale</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Saviano</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Pavone</surname>, <given-names>V.</given-names></string-name>, &amp; <string-name><surname>Di Natale</surname>, <given-names>P.</given-names></string-name> (<year>1999</year>). <article-title>Maroteaux–Lamy syndrome: Five novel mutations and their structural localization</article-title>. <source xml:lang="en">Biochimica et Biophysica Acta</source>, <volume>1453</volume>(<issue>2</issue>), <fpage>185</fpage>–<lpage>192</lpage>.<pub-id pub-id-type="pmid">10036316</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0104">
      <mixed-citation publication-type="journal" id="humu23613-cit-0104"><string-name><surname>Villani</surname>, <given-names>G. R. D.</given-names></string-name>, <string-name><surname>Grosso</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Pontarelli</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Chierchia</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Sessa</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Sibilio</surname>, <given-names>M.</given-names></string-name>, … <string-name><surname>Di Natale</surname>, <given-names>P.</given-names></string-name> (<year>2010</year>). <article-title>Large deletion involving exon 5 of the arylsulfatase B gene caused apparent homozygosity in a mucopolysaccharidosis type VI patient</article-title>. <source xml:lang="en">Genetic Testing and Molecular Biomarkers</source>, <volume>14</volume>(<issue>1</issue>), <fpage>113</fpage>–<lpage>120</lpage>.<pub-id pub-id-type="pmid">20143913</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0105">
      <mixed-citation publication-type="journal" id="humu23613-cit-0105"><string-name><surname>Voskoboeva</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Isbrandt</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>von Figura</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Krasnopolskaya</surname>, <given-names>X.</given-names></string-name>, &amp; <string-name><surname>Peters</surname>, <given-names>C.</given-names></string-name> (<year>1994</year>). <article-title>Four novel mutant alleles of the arylsulfatase B gene in two patients with intermediate form of mucopolysaccharidosis VI (Maroteaux–Lamy syndrome)</article-title>. <source xml:lang="en">Human Genetics</source>, <volume>93</volume>(<issue>3</issue>), <fpage>259</fpage>–<lpage>264</lpage>.<pub-id pub-id-type="pmid">8125475</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0108">
      <mixed-citation publication-type="journal" id="humu23613-cit-0108"><string-name><surname>Wang</surname>, <given-names>R. Y.</given-names></string-name>, <string-name><surname>Bodamer</surname>, <given-names>O. A.</given-names></string-name>, <string-name><surname>Watson</surname>, <given-names>M. S.</given-names></string-name>, &amp; <string-name><surname>Wilcox</surname>, <given-names>W. R.</given-names></string-name> (<year>2011</year>). <article-title>Lysosomal storage diseases: Diagnostic confirmation and management of presymptomatic individuals</article-title>. <source xml:lang="en">Genetics in Medicine</source>, <volume>13</volume>(<issue>5</issue>), <fpage>457</fpage>–<lpage>484</lpage>.<pub-id pub-id-type="pmid">21502868</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0110">
      <mixed-citation publication-type="journal" id="humu23613-cit-0110"><string-name><surname>Wood</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Bodamer</surname>, <given-names>O. A.</given-names></string-name>, <string-name><surname>Burin</surname>, <given-names>M. G.</given-names></string-name>, <string-name><surname>D'Almeida</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Feitz</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Giugliani</surname>, <given-names>R.</given-names></string-name>, … <string-name><surname>Harmatz</surname>, <given-names>P.</given-names></string-name> (<year>2012</year>). <article-title>Expert recommendations for the laboratory diagnosis of MPS VI</article-title>. <source xml:lang="en">Molecular Genetics and Metabolism</source>, <volume>106</volume>(<issue>1</issue>), <fpage>73</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="pmid">22405600</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0113">
      <mixed-citation publication-type="journal" id="humu23613-cit-0113"><string-name><surname>Yang</surname>, <given-names>C. F.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>J. Y.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>S. P.</given-names></string-name>, &amp; <string-name><surname>Tsai</surname>, <given-names>F. J.</given-names></string-name> (<year>2001</year>). <article-title>Mucopolysaccharidosis type VI: Report of two Taiwanese patients and identification of one novel mutation</article-title>. <source xml:lang="en">Journal of the Formosan Medical Association</source>, <volume>100</volume>, <fpage>820</fpage>–<lpage>823</lpage>.<pub-id pub-id-type="pmid">11802522</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0114">
      <mixed-citation publication-type="journal" id="humu23613-cit-0114"><string-name><surname>Zanetti</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ferraresi</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Picci</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Filocamo</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Parini</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Rosano</surname>, <given-names>C.</given-names></string-name>, … <string-name><surname>Scarpa</surname>, <given-names>M.</given-names></string-name> (<year>2009</year>). <article-title>Segregation analysis in a family at risk for the Maroteaux–Lamy syndrome conclusively reveals c.1151G&gt;A (p.S384N) as to be a polymorphism</article-title>. <source xml:lang="en">European Journal of Human Genetics</source>, <volume>17</volume>(<issue>9</issue>), <fpage>1160</fpage>–<lpage>1164</lpage>.<pub-id pub-id-type="pmid">19259130</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0115">
      <mixed-citation publication-type="journal" id="humu23613-cit-0115"><string-name><surname>Zanetti</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Önenli‐Mungan</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Elcioglu</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Özbek</surname>, <given-names>M. N.</given-names></string-name>, <string-name><surname>Kör</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Lenzini</surname>, <given-names>E.</given-names></string-name>, … <string-name><surname>Tomanin</surname>, <given-names>R.</given-names></string-name> (<year>2014</year>). <article-title>Molecular analysis of Turkish Maroteaux–Lamy patients and identification of one novel mutation in the arylsulfatase B (ARSB) gene</article-title>. <source xml:lang="en">JIMD Reports</source>, <volume>14</volume>, <fpage>1</fpage>–<lpage>19</lpage>.<pub-id pub-id-type="pmid">24243352</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0116">
      <mixed-citation publication-type="journal" id="humu23613-cit-0116"><string-name><surname>Zeng</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Fan</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Gu</surname>, <given-names>X.</given-names></string-name>, &amp; <string-name><surname>Yu</surname>, <given-names>Y.</given-names></string-name> (<year>2017</year>). <article-title>Molecular defects identified by whole exome sequencing in a child with atypical mucopolysaccharidosis IIIB</article-title>. <source xml:lang="en">Journal of Pediatric Endocrinology and Metabolism</source>, <volume>30</volume>(<issue>4</issue>), <fpage>463</fpage>–<lpage>469</lpage>.<pub-id pub-id-type="pmid">28306536</pub-id></mixed-citation>
    </ref>
    <ref id="humu23613-bib-0117">
      <mixed-citation publication-type="journal" id="humu23613-cit-0117"><string-name><surname>Zheng</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Sheng</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Cheng</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>Z.</given-names></string-name>, … <string-name><surname>Liu</surname>, <given-names>L.</given-names></string-name> (<year>2014</year>). <article-title>Analysis of clinical features and arylsulfatase B gene mutation in thirteen Chinese children with mucopolysaccharidosis type VI</article-title>. <source xml:lang="en">Chinese Journal of Pediatrics</source>, <volume>52</volume>(<issue>6</issue>), <fpage>403</fpage>–<lpage>408</lpage>.<pub-id pub-id-type="pmid">25190157</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
